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Abstract 
Meditation and its related practices have become increasingly popular over the past 
10 years, especially in Western society. As a result, the scientific community has 
focused its efforts on determining whether meditation exerts a physiological effect 
that is beyond that of a placebo and the exact mechanisms by which this may occur. 
The relatively new-found affordability and availability of gene array technologies 
have provided researchers with a quick method of determining gene expression 
changes associated with meditation. Gene expression changes provide preliminary 
insights on the mechanisms by which meditation may exert any specific effects. 
A literature review of the entire English-speaking database of studies that 
investigated gene expression changes associated with meditation, although different 
definitions of meditation were studied, revealed that there were no studies comparing 
two different definitions of meditation. I took this opportunity to conduct a 
randomised controlled trial consisting of 50 healthy participants (25 in each 
treatment arm)  and comparing two different definitions of meditation, namely 
Sahaja yoga (mental silence meditation) and a form of mindfulness known as body 
scan meditation, with the intention of determining whether there are distinct 
biological differences between two different definitions of meditation. Also I aimed 
to determine whether the mental silence approach to meditation could elicit gene 
expression changes.   
Blood samples were collected from each participant before and after a 6-week 
intervention period during which they were asked to attend a 1-hour intensive 
meditation class per week and practice for 15 minutes twice a day at home. RNA was 
then extracted from the whole blood using the Tempus Spin RNA isolation kit and 
submitted to the Ramaciotti Centre for analysis using the Affymetrix Human 
Genome U219 array plate. Gene data was checked and analysed using Partek 
Genomic Suite 6.6 and analysis of variance (ANOVA) was used to determine the 
significant gene expression changes.  
 iv 
 
The results suggested that mental silence and body scan meditations are able to elicit 
significant gene expression changes. Categories of genes that had significant changes 
in expression included immune system/inflammation, cancer and cell structure and 
function. Furthermore, it was found that mental silence and body scan meditation 
altered the expression of a vastly different number of genes (16 vs 48 respectively). 
Comparing the gene functions to the literature also led to the speculation that mental 
silence was associated with potentially more favourable health effects as compared to 
the body scan meditation group.  
In conclusion, it is shown that two different definitions of meditation are able to 
change the expression of genes in distinct ways and that the mental silence definition 
of meditation may exert its biological effects by altering the expression of genes 
related to the immune system/inflammation, cancer and cell structure and function. 
Owing to the differences in gene expression changes between the two definitions of 
meditation, both definitions may affect the body differently. Future studies are also 
proposed with a strong focus on large scaled RCTs comparing different definitions of 
meditation.  
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Introduction 
Over the past 30 years, meditation and related mind–body practices have attracted 
progressively greater attention from the scientific and health-care community. This 
has led to a growing body of evidence describing how these practices might affect 
mental and physical functions.  
Medical practitioners and psychologists seem to be the professions demonstrating the 
most interest. In 2005, M. M. Cohen et al. published the results of a survey involving 
a representative sample of 2000 GPs across Australia that assessed their attitudes 
toward complementary and alternative therapies, one of which was meditation (M. 
M. Cohen, Penman, Pirotta, & Da Costa, 2005). The study showed that 82% of GPs 
rated meditation as having moderate to high potential effectiveness in the treatment 
of health issues. Interestingly, meditation was actively encouraged by 65% of the 
GPs, coming second only to “massage” at 69%. The survey also showed that despite 
the fact that medical practitioners were comfortable with the idea of meditation, they 
lacked any formal training on the topic. Furthermore, 27% (the highest percentage 
out of all the therapies covered in the survey) of GPs indicated that they would like 
further training on meditation in the form of an introductory workshop. There are 
two other surveys in the peer-reviewed literature describing similar patterns of 
attitude and perception amongst mainstream medical practitioners regarding 
meditation (Gryffin, Chen, & Erenguc, 2014; Pirotta, Cohen, Kotsirilos, & Farish, 
2000).  
With regard to consumers, in 2012 in the US the National Centre for Complementary 
and Integrative Health released the results of a national survey (L. I. Black, Clarke, 
Barnes, Stussman, & Nahin, 2015; Clarke, Black, Stussman, Barnes, & Nahin, 
2015). The results indicated that approximately 18 million people had tried 
meditation at some stage in their lives. This may be due to the growing perception 
that meditation can help manage pain and reduce stress (Khoury et al., 2013; S. H. 
Kim, Schneider, Kravitz, Mermier, & Burge, 2013; Park, 2013; Simkin & Black, 
2014; Zeidan, Grant, Brown, McHaffie, & Coghill, 2012). 
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The most authoritative scientific reviews, and most researchers involved in fields of 
research that intersect with meditation, agree that despite meditation‟s substantial 
popularity amongst both professionals and the broader community, there is still a 
lack of consistent evidence to support the idea that meditation has a specific 
therapeutic effect beyond that of placebo. This conundrum stems from the fact that 
there are two fundamental questions that are yet to be satisfactorily answered about 
meditation. Answering these questions is essential for this conundrum to be resolved 
and to thus allow for significant progress in the field of meditation research. Despite 
the importance of answering them few researchers have attempted to develop 
answers that might be empirically testable let alone have been tested (Ospina et al., 
2007).  
The first question – what is meditation? 
The first of these two fundamental questions is: what is the definition of meditation? 
Despite its origins, the definition of meditation appears to vary between authors, 
historical texts and spiritual philosophies. Numerous attempts have been made to 
create formal definitions; however there is still no consensus definition despite 40 
years of Western scientific research into meditation. Some examples of attempts to 
define meditation include: 
a family of self-regulation practices that focus on training attention and awareness 
in order to bring mental processes under greater voluntary control and thereby 
foster general mental well-being and development and/or specific capacities such 
as calm, clarity, and concentration (Walsh & Shapiro, 2006).  
The authoritative National Centre for Complementary and Alternative Medicine 
defines it as “a conscious mental process that induces a set of integrated 
physiological changes termed the Relaxation Response” (National Center for 
Complementary and Alternative Medicine, 2004). 
Currently in the West meditation is commonly associated with Buddhism and hence 
Buddhist ideas about meditation – of which mindfulness is without doubt the most 
prominent. Mindfulness has been defined by Jon Kabat-Zinn, probably its most well-
known proponent, as “paying attention in a particular way; on purpose, in the present 
moment, and non-judgmentally” (Kabat-Zinn, 1994). 
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However, scholars widely acknowledge that meditation pre-dated Buddhism by 
thousands of years. There are numerous texts describing meditation and its 
associated ideas in pre-Buddhist Hindu texts for example, making it obvious that the 
origins of meditation go as far back as 7000 BC (Feuerstein, 2006; Mascaro, 1965; 
Srinivasachariar & Sastri, 1946). Amongst these texts is a variety of discussions 
about meditation and its related philosophies. Within these texts one finds a more 
ancient idea of meditation that both predates mindfulness and is conceptually specific 
and distinct from it, as well as the other more modern concepts of meditation 
described above.  
Mental silence 
In the Katha Upanishad (thought to be written sometime during the first millennium 
BC) the meditative experience is described as “When the five senses and the mind 
are still, and reason itself rests in silence, then begins the path supreme” (Mascaro, 
1965).  
This notion of the “still mind” is reflected in the even more ancient texts of the 
Mahabharata mythology (approximately 3000 BC), where a sage describes the nature 
of meditation to his audience: 
He does not hear…smell…taste…see…or experience touch…his mind ceases to 
imagine…He desires nothing, and like a log he does not think (Feuerstein, 2006). 
This description appears to make it even clearer that the defining feature of 
meditation may in fact be the experience of non-thought while remaining fully alert 
and aware, that is, “mental stillness” or “mental silence”. The Sanskrit terminology 
for this specific state is nirvichara samadhi (Patanjali, Prabhavananda, & Isherwood, 
1991). 
The concept of “mental silence” has received relatively little attention in the Western 
scientific literature, however there is a small but growing body of research 
suggesting that it is worthy of more attention. Mental silence meditation (MSM) 
involves a number of unique and specific experiential features:  
• present moment awareness 
• expanded consciousness 
• positive mood 
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• a sense of integration/synergy of faculties 
• positive health/wellness in all spheres (bio-psycho-social and spiritual) 
• a sense of cosmic connection and unity 
• trans cognitive/beyond thought 
• specific somatic sensations/descriptors that somehow reflect intuitive 
knowledge. 
 
The second question – is there a specific effect? 
The second question is: does meditation have a specific effect? That is, does it have 
an effect above and beyond placebo, and if such an effect is present, what might its 
biological mechanism be?  
The placebo effect is a “psychobiological phenomenon by which an improvement in 
health/behavioural outcomes which are not attributed to the intervention 
administered can be measured” (Benedetti, Mayberg, Wager, Stohler, & Zubieta, 
2005). Up until recently, the scientific community has essentially been divided into 
several categories in regards to their attitude to meditation and its apparent effects. I 
summarise these below.  
Sceptics 
The first category argues that despite the large volume of research done on 
meditation there is still insufficient high quality evidence to support the notion that 
meditation in general has a specific effect (Manocha, 2008; Ospina et al., 2007). The 
facts are that only a small percentage of the thousands of studies done on meditation 
are actually randomised control trials (RCTs), and that within this small subset of 
studies only a minority use credible methods to control for non-specific (placebo) 
effects. Within this very small subset of rigorously designed placebo, controlled trials 
the evidence for an effect beyond that of placebo is at best mixed (Ospina et al., 
2007).  
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Pragmatists 
The second category acknowledges the concerns raised by the above group. However 
they argue that despite the absence of a clearly demonstrable specific effect, the 
clinical improvements regardless of the specific cause are respectable and clinically 
advantageous and hence should be used. To justify their position, they explain that 
there is a substantial body of evidence for benefit from studies with an underlying 
conceptual design, that is, to compare “treatment as usual” to “treatment as usual 
PLUS meditation”. Many of these studies demonstrate positive effects in favour of 
the combination approach and hence are interpreted to reflect favourably on 
meditation and hence its clinical potential (Barnhofer et al., 2009; Kabat-Zinn et al., 
1998; Saeed, Antonacci, & Bloch, 2010; Teasdale et al., 2000; Visceglia & Lewis, 
2011). The weakness is that the apparent effect may nevertheless be the result of 
non-specific effects overlain on top of the standard treatment regime. While this line 
of reasoning is pragmatically correct it ignores the fact that the same benefits may 
accrue from non-meditative interventions. It also assumes that meditation is not 
associated with a significant cost or risk.  
Optimists 
This third category argues that thousands of both controlled and uncontrolled studies, 
despite the lack of clarity afforded by these methodologies, is sufficient indication of 
the therapeutic potential to warrant broader adoption. The proponents argue that the 
combination of these low quality studies and “common sense” are sufficient 
justification with respect to meditation because of its apparently benign nature. This 
perception ignores important issues such as: the fact that some meditation techniques 
can be arduous, expensive and time consuming; there is a growing recognition that 
meditation can occasionally be associated with adverse experiences, sometimes 
serious ones; and that there is an opportunity cost wherein practitioners might be 
better off expending their time and effort on a more demonstrably effective 
intervention. These optimists frequently co-opt the arguments and documents from 
the other categories when it suits them to support their position. 
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Traditionalists 
The herbal and traditional medicines industry, faced by demands from government 
regulators to justify the existence of their products, frequently fall back on the 
“historical evidence” argument (Micozzi, 1998; Pirotta et al., 2000). This line of 
reasoning posits that although there is a dearth of rigorous modern scientific 
evidence to support the clinical use of their products there is a considerable history of 
traditional generic usage that can extend for hundreds and sometimes thousands of 
years (Crellin, 2001). This “historical evidence”, it is argued, is sufficient to warrant 
modern usage. The success of the argument is proven by the fact that these products 
are widely available in shops with the blessing of the regulators despite the absence 
of modern clinical trial evidence. Meditation enthusiasts and the organisations that 
market meditation to them have embraced this strategy as a way of undermining the 
sceptics‟ calls for more evidence regarding meditation.  
Fanatics 
This category overlaps somewhat with the traditionalists but embodies an even more 
extreme line of thinking. These people, who are mostly meditators, consider the need 
for any kind of justification or evidence as irrelevant. They embrace the idea that 
meditation should be universally practiced by all. They frequently ignore or play 
down considerations of risk or cost. The fanatics deride attempts to scientifically 
study meditation as attempts to confine the experience of meditation to the 
limitations of rationality. Much of the rhetoric used by this group is part of the larger 
anti-science narrative. The sceptics reciprocate by labelling the claims of the 
traditionalists and fanatics as spurious and that in fact the traditionalists and the 
fanatics are themselves a living demonstration of the dangers of irrational and 
indiscriminate thinking about meditation. 
New wave 
Finally, there is a category that in many ways is smaller than all these others but it 
acknowledges that each of the above categories has some, albeit variable, level of 
validity. It is this category to which this researcher belongs. 
Most importantly, the issue identified by the sceptics, that the evidence for an effect 
beyond that of placebo is still equivocal is essentially true. However, one of the 
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reasons for this is that a fundamental error made by the sceptics and to some extent 
by all the above-mentioned categories, is the assumption that meditation is a single 
entity. Until now, meditation has been recognised as being a broad range of different 
practices and methods that aim to increase general wellbeing and reduce stress. 
Hence, it may be possible that different techniques of meditation may be invoking 
different effects. This is why the current broad definition of meditation must be 
dissected in order for a thorough investigation into whether or not different practices 
invoke different effects, if any. And this will occur in the Literature Review and the 
following sections as I discuss the various attempts at understanding the physiology 
of „meditation‟. 
Evidence of a specific effect 
Difficulties in excluding placebo effects stems from the lack of appropriate control 
strategies, a need for randomisation or methodologically robust study designs and 
also our initial problem of a consensus definition of meditation.  
Although the mental silence concept has not gained much traction, there is a growing 
body of evidence suggesting that it may have specific effects as outlined below.  
In India Rai et al. conducted the first series of randomised controlled trials involving 
the mental silence concept by studying the clinical and physiological effects of the 
Sahaja yoga meditation technique (Panjwani, Gupta, Singh, Selvamurthy, & Rai, 
1995; Panjwani et al., 1996; Rai, Setji, & Singh, 1988). The findings of these RCTs 
can be summarised as follows.  
When compared to a sham meditation, Sahaja yoga was found to reduce 
physiological arousal and increase the activity of the parasympathetic nervous 
system. This led to a reduction in heart rate, respiratory rate, blood pressure, oxygen 
metabolism and urinary vanillylmandelic acid (Rai et al., 1988). Studies during the 
1980s determined that urinary vanillylmandelic acid proved to be a useful 
biochemical marker of psychological stress (Fukuda et al., 1996).  
In another study when comparing epilepsy patients to a control group and an exercise 
group which mimicked Sahaja yoga meditation, it was found that seizure frequency 
was decreased by 62% at 3 months and 86% at 6 months for the intervention group. 
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This also coincided with alterations in electroencephalogram readings (increased 
delta and alpha waves) (Panjwani et al., 1995).  
And in another study, significant changes in galvanic skin resistance, blood lactate 
and urinary vanillylmandelic acid were observed at 3 months and 6 months during 
the intervention as compared to the control group (Sahaja yoga meditation imitation 
group) (Panjwani et al., 1996).  
In Australia, Manocha et al. conducted a series of trials to further investigate the 
specific effects of mental silence and expand on the work done by Rai et al. 
(Manocha, Marks, Kenchington, Peters, & Salome, 2002). The RCT study designs 
used by Manocha et al. aimed to address the common methodological design flaws 
of previous studies in the hope of more reliably identifying a specific effect 
(Manocha, Black, Sarris, & Stough, 2011). Manocha‟s first RCT looked at the effects 
of mental silence meditation on asthma suffers and whether it could improve mood, 
symptoms and airway hyper-responsiveness (Manocha et al., 2002). Manocha‟s 
second RCT looked at the effects of the same approach to meditation on work stress 
(Manocha et al., 2011). Both studies showed that meditation provided significant 
benefits in a number of key parameters when compared to study interventions 
designed to control for important non-specific effects arising from factors such as 
credibility and expectancy, reduced physiological arousal and therapeutic contact. 
The RCTs appear to confirm that mental silence exerts specific effects.  
Given the previous considerations, the observation of repeatable, specific effects is a 
remarkable finding worthy of further investigation. Importantly, neither Rai‟s nor 
Manocha‟s trials were designed to give much insight into the biological mechanisms 
responsible for these apparently specific effects. Additionally the trials were not 
designed to provide insights into any difference that might exist between different 
definitions of meditation and yet clearly the results of these studies point towards the 
notion that some definitions of meditation may be more likely to generate a specific 
effect than others.  
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Understanding the potential biological mechanisms 
of meditation 
The most widely accepted explanation on how meditation might exert its biological 
impacts is that it acts via the relaxation response (Benson, Beary, & Carol, 1974a).  
The relaxation response is a spectrum of psycho-physiological changes associated 
with reduced physiological arousal. Physiological arousal and the relaxation response 
occur as a result of activity converging on pathways within the autonomic nervous 
system. A brief explanation of the interactions between the autonomic nervous 
system (ANS), central nervous system (CNS) and the physiology of peripheral 
organs follows. 
Physiological arousal 
The nervous system is comprised of the peripheral nervous system and the central 
nervous system. The peripheral nervous system is divided into the somatic and 
autonomic nervous systems. The CNS is comprised of the brain and spinal cord 
(Brodal, 2010).  
The ANS is further subdivided into the sympathetic nervous system (SNS) and the 
parasympathetic nervous system (PNS), both of which are fed by neuronal pathways 
stemming from the hypothalamus located in the CNS. Both the SNS and PNS 
regulate a range of biological functions over which we have minimal control. These 
include heart rate, breathing, digestion and regulation of blood flow (Brodal, 2010).  
Physiological arousal occurs as a result of engagement with stimuli in the 
environment and has been a focus of psychophysiological research for several 
decades. Physiological arousal involves the activation of the SNS via hypothalamic 
projecting neurons from the CNS. The activation of the SNS stimulates the release of 
the catecholamines (epinephrine and norepinephrine) from the adrenal medulla. 
These catecholamines diffuse through the blood stream and act on receptors in 
various organs and also on blood vessels resulting in a number of effects which 
include: increased heart rate, increased heart contractility, increased blood pressure 
as a result of an increase in total peripheral resistance, increased sensory alertness, 
constriction of pupils, increase in electro dermal activity, increased sweating and 
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increased respiratory rate (Azarbarzin, Ostrowski, Hanly, & Younes, 2014; Bradley, 
Miccoli, Escrig, & Lang, 2008; Noteboom, Barnholt, & Enoka, 2001).  
The relaxation response 
The relaxation response is characterised by a decrease in SNS activity and an 
increase in PNS activity, essentially a reversal of physiological arousal, which leads 
to the following typical effects: 
• slowing of heart rate  
• decrease in respiration  
• decrease in metabolism  
• increase in salivation and digestion  
• decrease in blood pressure  
• increase in alpha activity in the brain  
• subjective feeling of relaxation  
• subjective feeling of warmth and heaviness. 
The idea that meditation might work by eliciting the relaxation response has been 
investigated over the past few decades, with the first studies emerging in the 
literature in the 1970s. Since that time many studies were published that 
demonstrated that meditation was generally associated with physiological changes 
characteristically associated with a reduction in autonomic arousal. Herbert Benson‟s 
group pioneered this line of thinking with a series of studies that appeared to 
demystify meditation by demonstrating that its chief physiological effect was to 
reduce arousal (Avorn & Benson, 1974; Benson, Beary, & Carol, 1974b; Benson, 
Dryer, & Hartley, 1978; Benson, Rosner, Marzetta, & Klemchuk, 1974; Benson, 
Steinert, Greenwood, Klemchuk, & Peterson, 1975). At first, these physiological 
changes were associated with Transcendental Meditation (TM), a highly 
commercialised form of meditation which in the 1970s and early 1980s achieved 
such popularity, at least in the West, was what people understood as meditation 
(Delmonte, 1984; Holmes, Solomon, Cappo, & Greenberg, 1983). However, Benson 
soon discovered that many different approaches to meditation also triggered the same 
process of de-arousal. These different approaches included simple relaxation 
methods and even practices not previously categorised as meditation such as certain 
forms of prayer. For example a 1977 study comparing transcendental meditation, 
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general relaxation training and muscle relaxation via electromyograph biofeedback 
demonstrated that although the TM group significantly decreased physiological 
arousal, the other two control groups were equally as effective (Cauthen & Prymak, 
1977). Another study comparing TM to listening to music found that both groups 
were equally effective in decreasing oxygen consumption and carbon dioxide 
production (Fenwick et al., 1977).  
Benson coined the term “relaxation response” to describe this set of physiological 
responses (Benson, 1975). These findings represented a paradigm shift in the 
understanding of meditation and similar practices away from mystical and spiritual 
ideas and towards a more secular, non-denominational conceptualisation. This led to 
the widespread assumption that meditation could be physiologically defined by the 
relaxation response. The idea has had traction ever since with many researchers and 
authorities (e.g. as stated earlier the US National Centre for Complementary and 
Alternative Medicine).  
Although this way of understanding meditation was greeted with enthusiasm during 
the 1970s and 1980s, the fact was new studies provided evidence that many non-
meditative strategies also elicited the relaxation response. Many researchers 
supported the notion that the definition of meditation should be allowed to expand 
and accommodate strategies traditionally regarded as non-meditative but that could 
also elicit the relaxation response. Although this seemed like the easiest solution, it 
meant that almost any relaxing activity could be included in the definition of 
meditation. 
Some researchers argued that rather than dilute the concept of meditation, a different 
definition of meditation was required to support the perception that meditation was a 
specific and distinct entity (Cardoso, de Souza, Camano, & Leite, 2004). 
This dilemma highlights the need to define meditation clearly. Only then can we 
more fully test and hence understand the biological mechanisms by which meditation 
may act and how this differs from other non-meditative activities. The relatively 
nebulous and fluctuating conceptualisations of meditation appearing in both 
professional journals and popular media have served to exacerbate rather than 
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resolve the intertwined questions about its potential mechanisms and how it might be 
defined.  
Stress and stress reduction 
More sophisticated ideas about how meditation might influence human biology 
developed in parallel with the emergence of fields such as psychoneuroimmunology 
and the growing interest in the physiology of stress. Research from these fields has 
provided a rich source of hypotheses about how meditation might exert its effects on 
mind and body. 
What is stress? 
The term “stress” has become common vocabulary in Western culture and has been 
associated with a set of negative psychological conditions. Recent studies have 
linked stress to common health problems include: hypertension, heart disease, 
substance abuse, anxiety, depression, gastrointestinal disorders, cancer, headaches 
and back pain (S. Cohen, Janicki-Deverts, & Miller, 2007; Conti, Maccauro, & 
Fulcheri, 2011; Spruill, 2010; Yudkin, Kumari, Humphries, & Mohamed-Ali, 2000). 
Yet, its definitions vary within different contexts and different people. The first and 
most generic definition of stress was proposed by Hans Selye: “Stress is the 
nonspecific response of the body to any demand” (Selye, 1976).  
Despite the ongoing fluxes in defining what psychological stress is, its physiological 
impact can be characterised by short-term and sustained long-term changes. The 
short-term response or acute response has popularly been labelled the “fight or flight 
response” and is beneficial in a critical or life threatening situation. When these 
short-term stress events become frequent or prolonged, they result in chronic stress 
which over time may contribute negatively to a person‟s mental and physical health.  
Meditation and stress reduction 
It is well established that meditation is able to reduce the negative dimensions of 
psychological stress (Goyal, Singh, Sibinga, & et al., 2014). The biological 
mechanisms by which it does so are still somewhat unclear. It is currently thought 
that meditation influences the body at a molecular level through the reduction in 
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stress biomarkers and more recently, through the decreased expression of stress 
related genes.  
One commonly associated biomarker with stress is the steroid hormone cortisol. 
Researchers observed serum cortisol concentrations in meditators were significantly 
lower than compared to their control counter parts (Sudsuang, Chentanez, & 
Veluvan, 1991; Vandana, Vaidyanathan, Saraswathy, Sundaram, & Kumar, 2011). 
Other biomarkers for stress have also been widely accepted. Examples of these 
biomarkers include interleukin-6 (IL6), tumour necrosis factor a (TNF-a) and the 
more recently used C-reactive protein (CRP). Studies have shown that meditation 
also seems to influence the reduction of these markers of stress therefore giving us 
another possible mechanism through which it can exert its purported health effects 
(Creswell et al., 2012; T. W. W. Pace et al., 2010; Rosenkranz et al., 2013; Zgierska 
et al., 2008). It is also important to note that biomarkers and genes related to stress 
have a large degree of overlap with biomarkers and genes related to inflammation. 
Therefore, it may be possible that meditation‟s biological effects are mediated 
through interplay between stress and inflammatory pathways.  
Chronic inflammation and meditation 
Meditation is a lifestyle modification that is commonly associated with reduction of 
stress. As mentioned previously, the connection between stress and the genesis of 
chronic inflammatory mediators is well documented (Andrew Steptoe, Mark Hamer, 
& Yoichi Chida, 2007). It is plausible therefore that meditation might have a positive 
influence on chronic inflammation by reducing stress and possibly other pathways 
(Chiesa & Serretti, 2009; Manocha et al., 2011). The impact of meditation on chronic 
inflammation, and hence the risk of developing non-communicable diseases (NCDs) 
(cardiovascular disease, cancer, respiratory disease and diabetes) can therefore be 
assessed by measuring its impact on chronic inflammation markers. Epigenetic 
studies offer a convenient and powerful method to assess the impact of meditation on 
NCD risk. 
Inflammatory markers can be measured directly through serum concentrations and 
indirectly via gene chip array analysis. Gene expression levels can correlate, up to a 
certain extent, with concentrations of each inflammatory marker in the blood at the 
time the blood sample was taken (Vogel & Marcotte, 2012).  
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In 2012, Antoni et al. reported that those who participated in cognitive based stress 
management therapy (CBSM), displayed significant down regulation of pro-
inflammatory genes including IL6, TNF and IL1 (Antoni et al., 2012).  
Three separate studies exploring other various techniques of meditation including 
hatha yoga, Kirtan Kriya meditation and relaxation response sequence have also 
displayed down regulation (i.e. a beneficial reduction) of pro-inflammatory genes 
(Bhasin et al., 2013; D. S. Black et al., 2013; Kiecolt-Glaser et al., 2010).  
These studies suggest that it would be beneficial to determine what changes to gene 
expression may occur as a result of the mental silence experience and whether or not 
any such changes may be unique to it vis-a-vis other definitions of meditation.  
Immune function 
The immune system is the collection of cells, tissues and molecules that mediate 
resistance to infections; its physiological function can be summarised as follows 
(Abbas & Lichtman, 2010): 
• defence against infections 
• defence against tumours 
• its ability to cause cell injury and also induce cell repair 
• clearance of dead cells 
• its ability to induce chronic or acute inflammation 
• the recognition of tissue grafts and newly introduced proteins. 
There are two main branches of the immune system (innate and adaptive) and a brief 
summary of each is given.  
The innate immune system 
The innate immune system is the first to respond to an infection and its actions can 
be observed within 2-3 hours of infection. The following are key components of the 
innate immune system (Abbas & Lichtman, 2010): 
• Epithelial barriers of the skin and mucosal tissues provide a first line of 
defence against the external environment. Within these epithelial tissues 
reside cells and natural antibiotics, which aim to block the entry of infectious 
agents. 
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• neutrophils 
• monocytes/macrophages 
• dendritic cells 
• natural killer cells 
• mast cells 
• innate lymphoid cells 
• the complement system. 
The innate immune system has a unique response to microbes (which are 
microscopic living organisms capable of infection), allowing it to be distinguished 
from the adaptive immune system. 
The innate immune system aims to eliminate microbes through the induction of an 
acute inflammatory response and via antiviral defence mechanisms. Inflammation 
increases permeability of blood vessels, which allow immune cells to access the site 
of injury in greater amounts. This leads to the destruction of microbes, clearance of 
damaged cells and the promotion of cell repair. In contrast, antiviral defence 
mechanisms rely on the production of type 1 interferons that are secreted by dendritic 
cells. Type 1 interferons include IFN-α and IFN-β both of which are recognised by 
receptors on the infected cell. The binding of these interferons then leads to 
inhibition of viral gene expression and the degradation of the viral genome.  
Overall, the innate immune system is the first line of defence against infection and 
the quickest to respond. In addition, it plays a crucial role in providing signals to 
activate the adaptive immune system and to make sure that it responds only to 
infectious agents and minimises the chances of an auto immune reaction.  
Adaptive immune system 
The adaptive immune system requires the recognition of a pathogen and 
differentiation of lymphocytes before a significant immune response can be achieved 
against an infection. There are two main types of adaptive immune responses; 
humoural immunity and cell-mediated immunity (Abbas & Lichtman, 2010).  
Humoural immunity is carried out by immune cells known as B-lymphocytes. These 
immune cells produce proteins called anti-bodies that bind to sections of pathogenic 
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microbes (also known as antigens). Anti-bodies are produced in a response to an 
antigen and block their ability to infect host cells and infiltrate tissues in the body. 
The only disadvantage of anti-bodies is that they are unable to attack microbes which 
have already infected cells and reside within the cell structure. This is where the 
second branch of the adaptive immune system plays a role.  
The cell-mediated immune response is facilitated by T lymphocytes (commonly 
known as T helper cells). Once a cell has been infected, it displays the antigen on the 
cell surface. Circulating T lymphocytes recognise these antigens and either kill the 
infected cell or instruct the cell to destroy the microbes internally through lysosomal 
degradation (in the case of macrophages). The adaptive immune system has a 
number of key features which distinguishes it from the innate immune system: 
• It is very specific meaning that each antigen elicits its own specific response 
through the production of specific anti-bodies and receptors. 
• It is able to respond to a large diversity of antigens. 
• The adaptive immune system has memory, meaning that repeated exposure of 
the same antigen results in a faster and more effective immune response. 
• The ability to undergo clonal expansion means that once a antigen has been 
identified, a large number of antigen specific lymphocytes can be created 
from naïve lymphocytes. 
Immune function and meditation 
There is emerging evidence that mind–body related practices such as meditation may 
be able to modulate the immune response either through increased levels of 
inflammatory markers (as discussed previously) or through the increased levels of 
immune cells (Infante et al., 2014; Morgan, Irwin, Chung, & Wang, 2014). In my 
literature review there was only one study relating to immune gene expression 
changes (Antoni et al., 2012). This high quality study found that cognitive based 
stress management increased gene expression for the following genes: type I 
interferon response (IFIT1, IFIT2, IFIT3, IFI44, IFI44L, ISG15, MX2, OAS2, 
OAS3), type II interferon signalling (IFNG) and interferon signal transduction 
(STAT1, STAT2). As discussed previously, interferons are involved in their anti-
viral activity and therefore increased expression of these genes may lead to a superior 
anti-viral response than in those who did not meditate.  
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Cell structure and function 
A relatively new idea is that meditation may influence the body through its actions 
on cell structure and function components. Cells are the underlying basis of all living 
life forms including humans. “Cell Theory” is one of the fundamental basic 
principles of biology and states: 
• All living organisms are composed of cells 
• The cell is the basic unit of life 
• Cells arise from pre-existing cells 
• Energy flow occurs within cells 
• DNA is passed on from cell to cell 
• All cells have the same basic chemical composition. 
Homeostasis is process by which cells maintain and regulate their internal 
environment in response to constant changes in the external environment. The ability 
to maintain homeostasis is a function of how healthy a cell is and how long it can 
survive. A cell maintains homeostasis by controlling what enters and leaves it 
through its plasma membrane and thus controlling factors essential for survival. 
These include: 
• maintaining intracellular metal ion concentrations within a narrow range 
• maintaining pH levels  
• removing waste products 
• regulating temperature 
• producing energy  
• maintaining a barrier from the external environment 
• producing carrier proteins and receptors to respond to the external 
environment 
• regulating gene expression. 
The above list is by no means exhaustive and only highlights the basic processes that 
are required for cell homeostasis. The genes that code for proteins involved in these 
processes are far larger in number, however they can broadly be categorised by the 
following: 
• heat shock proteins  
• enzymes  
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• membrane transporters  
• ion channels 
• ligand gated ion channels 
• G-protein coupled receptors 
• cell structural proteins. 
Numerous recent studies and reviews have already established that psychological 
stress can shorten the lengths of structures called telomeres (Epel et al., 2004; 
Oliveira et al., 2016; Starkweather et al., 2014; Tzanetakou, Nzietchueng, Perrea, & 
Benetos, 2014). Telomeres are DNA sequences at the end of each chromosome that 
protect it from nucleolytic degradation, unnecessary recombination, repair and inter-
chromosomal fusion. Every time a cell divides, the telomere shortens and as this 
continues, it eventually induces cell senescence (which leads to cell death).  
As discussed previously, meditative practices have been shown to reduce stress and 
stress biomarkers. The connection between stress and telomerase led researchers to 
investigate the link between mind body practices, such as meditation and whether or 
not they are able to influence telomerase activity. The literature surrounding this 
notion has grown over the past 5 years and a number of publications confirmed the 
idea that meditative practices might beneficially influence the activity of telomerase 
and thus prolong cell life (Jacobs et al., 2011; Kumar, Yadav, Yadav, Tolahunase, & 
Dada, 2015; Lengacher et al., 2014). Additionally, a 2013 meta-analysis of four 
mindfulness meditation RCTs concluded that mindfulness significantly increases 
telomerase activity in peripheral blood mononuclear cells (Schutte & Malouff, 2014).  
Based on these studies it may be plausible to expect that mental silence may alter 
telomerase or the expression of its related genes and give us another possible 
explanation of how it might exert its biological effects. In addition, it is also possible 
that the two different definitions of meditation may alter the expression of other 
cellular structure and function genes. However, since these genes are involved in an 
exponential number of gene pathways, it would be impossible to determine the 
impact on the human body.  
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Introducing epigenetics 
Over the last decade or so the field of epigenetics has emerged as a new and 
powerful way to understand the biological mechanisms that regulate health and 
disease. Epigenetics is a molecular biology discipline that differs from genetics 
because, rather than focusing on the identification of genes that lead to the 
expression of a certain phenotype or disease risk, or the inheritance of such genes, it 
examines the mechanisms that regulate the expression of genes. Epigenetics is thus 
predicated on a new understanding of how the genome operates – as a dynamic 
system that can act in very short time periods to activate or deactivate a gene and 
hence its ability to support the production of the proteins that it codes for (Allis, 
Jenuwein, & Reinberg, 2007).  
In other words a single genome can have multiple, different epigenetic and hence 
phenotypic destinies depending on which environmental factors might act on it at 
crucial time points in the organism‟s development. This is why the new field of 
epigenetics is seen in many ways to contradict the traditional view of the genome – 
that our genes are locked into an unchangeable pathway of development after they 
are produced. In traditional genetics, DNA replication and gene expression are 
controlled by elements such as promoters, enhancers or binding sites for repressor 
proteins which are present or absent in the DNA sequence itself. In contrast, 
epigenetic mechanisms modify the conformation of the DNA and the accessibility of 
other factors to DNA without altering the DNA sequence. It thus refers to a level of 
control external to the DNA which modifies how the DNA is read rather than to 
alteration of the DNA sequence itself. This external control allows for genes to be 
effectively switched between the “on” or active state and the “off” or inactive state, 
both of which can occur without causing changes to the DNA sequence (Jaenisch & 
Bird, 2003). This phenomenon adds an extra explanation as to why although all cells 
contain the same DNA, they can display different phenotypes. For example, our body 
contains a myriad of cells ranging from skin cells to liver cells all of which have the 
same DNA present. The phenotype displayed is clearly attributed to epigenetic 
regulation of the DNA. Another differentiating factor of epigenetics is that these 
gene expression changes can be inherited by the next generation (García-Giménez, 
2015; Heard & Martienssen, 2014). Epigenetics therefore offers an understanding of 
the biological mechanisms that underlie virtually every aspect of biological function.  
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Most importantly, epigenetic tests have now reached a level of breadth, 
sophistication and affordability that allows broad insights into the full spectrum of 
physiological systems that might become more or less active over even short time 
periods in response to a given stimulus.  
Previously, investigations into the biology of meditation were restricted to relatively 
narrow avenues of enquiry, the commonest being: 
• peripheral physiological measures of autonomic activity such as: blood 
pressure, heart rate, skin temperature, galvanic skin resistance and more 
recently heart rate variability (Chatterjee, Ray, Panjwani, Thakur, & Anand, 
2012; Chung, Brooks, Rai, Balk, & Rai, 2012; Yunati, Deshp, & Yuwanate, 
2014)  
• neuroendocrine factors such as circulating stress hormones (catecholamines, 
cortisol), endorphins, oxytocin, ACTH and aldosterone (Infante et al., 1998; 
Turakitwanakan, Mekseepralard, & Busarakumtragul, 2013) 
• central nervous system assessment methods aimed at assessing brain activity 
such as electroencephalogram, functional magnetic resonance imaging, 
positron emission tomography and magnetoencephalography (Aftanas & 
Golocheikine, 2001; Hernandez, Suero, Rubia, & Gonzalez-Mora, 2015) 
The advent of the microarray gene chip 
The term microarray refers to the structured arrangement, “array”, of the probes of 
interest in a grid format used at a small scale, “micro”. A microarray gene chip is an 
apparatus where single-stranded DNA oligonucleotides are affixed to the solid 
surface (usually silicon or nylon). The principle of DNA microarray is based on the 
fact that single-stranded DNA has a natural affinity to bind to its complementary 
DNA or RNA strands (given the right chemical conditions). As the single-stranded 
DNA has a high affinity to become double stranded, when samples are added to the 
surface of the microarray they become hybridised to the affixed complementary 
oligonucleotides. These affixed oligonucleotides are created from a fragment of 
genomic DNA, cDNA, PCR products or chemically synthesised oligonucleotides that 
have already been sequenced and are available from a library.  
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Microarrays allow for the multiple parallel gene expression analysis of thousands of 
genes by binding the transcribed mRNAs of expressed genes, and are capable of 
covering the whole genome from a sample as little as 50–100 ng of total RNA. The 
advantage of this is that instead of being limited to analysing a smaller number of 
genes relating to specific body systems, researchers can now do a genome wide 
expression analysis which covers multiple body systems at once.  
There are three major commercial gene expression platforms for DNA microarray. 
These include: 
• Affymetrix (Affymetrix, Santa Clara, CA, USA).: utilises in situ synthesis of 
oligonucleotides directly onto a quartz wafer (known as a gene chip). 
• Illumina (Illumina, San Diego, CA, USA) : 3-micron silicon beads are 
randomly distributed on either planar silicon slides or fibre optic bundles. 
These 3-micron beads are covered with thousands of copies of a specific 
oligonucleotide in order to capture complementary sequences when a sample 
is added. 
• Agilent (Affymetrix, Santa Clara, CA, USA): Inkjet printing is used to print 
oligo monomers onto a special glass slide. This produces 60-mer length 
oligonucleotides which are printed base by base. 
The gene expression studies on meditation which are discussed in the literature 
review (see Table 1) all use different gene array methods. For example Affymetrix 
was used by three studies (Bhasin et al., 2013; Dusek et al., 2008; Q. Z. Li, Li, 
Garcia, Johnson, & Feng, 2005), Illumina was used by 4 studies (Antoni et al., 2012; 
D. S. Black et al., 2013; Creswell et al., 2012; Qu, Olafsrud, Meza-Zepeda, & 
Saatcioglu, 2013). Overall the different platforms of microarray achieve the same 
purpose with differences mainly in costs and ease of use. In summary, the unique 
utility of the epigenetic approach is that it provides an insight into the function of 
multiple body systems with a single, simple battery of tests from a single sample of 
blood.  
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The biological mechanisms of epigenetic regulation 
The mechanisms by which epigenetic changes occur include (but are not limited to) 
three main processes:  
1. DNA methylation (Smith & Meissner, 2013) 
2. histone modification/chromatin remodelling (Bannister & Kouzarides, 2011) 
3. RNA interactions. (Holoch & Moazed, 2015) 
Methylation 
The most well-known epigenetic modification is DNA methylation which results in 
the inhibition of transcription of the gene involved. Methylation occurs exclusively 
on the dinucleotide sequence which is a link between the base cytosine and the base 
guanine via a phosphate bond (also known as CpG). It has been noted that the 
majority of CpGs are methylated and those CpGs which are not methylated are 
usually clustered together to form CpG islands. Gene expression requires the 
transcription machinery to be able to easily access the gene promoter region (part of 
the sequence that is essential in that specific gene‟s transcription). By methylating 
these promoter regions, it can directly obstruct the transcriptional machinery 
resulting in the lack of a functional gene product (Lim & Maher, 2010; Razin & 
Kantor, 2005).  
Histone modification 
In the cell nucleus DNA is wrapped around histone proteins to form units called 
nucleosomes. There are 5 families of histone proteins, H2A, H2B, H3, H4 (core 
histones) and H1/H5 (linker histones). Each nucleosome is composed of DNA 
wrapped around 8 core histone proteins which are linked to other nucleosomes via 
linker histones and linker DNA. Histone modifications affect the way DNA is 
wrapped around them which in turn leads to the different expression of different 
genes. Histone acetylation and methylation are two methods by which histones can 
be modified (Rice & Allis, 2001). Both these processes are reversible. Histone 
acetylation occurs on lysine residues on the histones and is catalysed by histone 
acetyltransferases. This acetylation neutralises the positive charge on the lysine 
residue thereby reducing affinity between the histones and DNA allowing for the 
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transcriptional machinery to gain access to the DNA (up regulation of DNA 
transcription). The opposite occurs with the assistance of histone deacytelases 
(HDACs), causing the DNA and the lysine to gain affinity thereby disrupting gene 
expression. Histone methylation involves the methylation of the lysine residue on the 
histones. However the methylation of different lysines can result in either 
suppression or expression of the genes, as compared to DNA methylation which only 
causes gene suppression. Methylation of the lysine can also be de-methylated by the 
catalyst lysine demethylase (Cheung & Lau, 2005; Imhof, 2006).  
Chromatin remodelling 
This occurs via protein complexes called chromatin remodelling complexes. They 
use the energy of ATP hydrolysis to change the state of the chromatin via the 
manipulation of the nucleosomes that the chromatin is wrapped around (Clapier & 
Cairns, 2009). It is also apparent that chromatin remodelling machinery works in 
tandem with histone modification enzymes and that both processes are essential for 
DNA methylation and de-methylation. Similar to histone modification enzymes, 
there are 4 different classes of remodelling complexes all of which share some basic 
properties: a higher affinity for the nucleosome than the DNA itself; domains which 
are able to recognise covalent histone modifications; a region for breaking histone-
DNA contacts, domains/proteins that regulate the ATPase domain; domains/proteins 
required for interaction with chromatin or transcription factors. Although they all 
have these properties in common, they also have distinctive properties which differ 
in the composition of the complex subunits and the way they actually interact with 
the nucleosomes (Geiman & Robertson, 2002).  
Non-coding RNAs 
Non-coding RNA (ncRNA) molecules are transcribed from DNA that is not 
translated into proteins but rather plays a role in the regulation of gene expression via 
interactions with histones, the DNA and gene silencing. The ncRNAs are divided up 
into short ncRNA and long ncRNAs, with the short ncRNAs being further divided 
into microRNAs (miRNA), short interfering RNAs (siRNAs) and piwi-interacting 
RNAs (piRNAs). MiRNAs bind and either degrade, cleave or block translocation of 
specific RNA transcripts to regulate the expression of the messenger RNA‟s target. 
In addition to the functions of miRNA, siRNA is able to induce methylation and 
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chromatin condensation by binding to a RNA-induced transcriptional silencing 
complex. Finally piRNAs are transcribed and then bind to PIWI proteins resulting in 
epigenetic regulation and transposon control (a sequence of DNA that can change its 
position within the genome) (Esquela-Kerscher & Slack, 2006; Tollefsbol, 2014).  
Psychosocial genomics 
In recent years, it has become well established that not only physical changes in our 
environment but also psychological, and possibly even social and cultural changes 
can lead to alterations in gene expression (Provencal & Binder, 2015). Gene 
expression changes associated with the mind–body interaction are now encompassed 
by a field called “psychosocial genomics”(Rossi, 2002).   
One example of psychosocial genomics occurs during pregnancy. Over the past 
decade there has been mounting evidence that changes in the environment during 
pregnancy can influence the baby in utero via epigenetic mechanisms. This has come 
to be known as the “developmental origins of health and disease” paradigm. The 
paradigm covers a number of themes including: 
• the influence of diet during pregnancy and how this may affect the likelihood 
of the baby becoming obese during adulthood 
• the consequences of mismatch between prenatal and postnatal environments 
and how this can lead to chronic disease later in life  
• psychobiological effects of stress during pregnancy on the development of the 
fetus and later outcomes. 
The effects of stress on prenatal development has been well documented with effects 
which have been observed to last into infancy, childhood, adolescence and even 
adulthood. Effects have included: 
• impaired parts of memory and learning such as object recognition and spatial 
memory (prenatal stress induces spatial memory deficits and epigenetic 
changes in the hippocampus indicative of heterochromatin formation and 
reduced gene expression) 
• increased risk of neurological and psychiatric disorders (stress-induced 
perinatal and transgenerational epigenetic programming of brain development 
and mental health) 
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• reduction in birth weight and subsequently increasing the likelihood of 
disorders of cardiovascular function, glucose homeostasis, hypothalamic–
pituitary–adrenal (HPA) axis activity and anxiety-related behaviours in 
adulthood (prenatal stress, glucocorticoids and the programming of adult 
disease). 
This highlights the idea that stress during pregnancy can induce long lasting 
epigenetic changes in the fetus which result in mental and physical health issues that 
may last well into adulthood. On the other hand, epigenetic studies focusing on 
adults have established that stress, post-traumatic stress disorder and depression can 
alter the expression levels of stress related genes (Cole, 2010). Therefore it is 
reasonable to expect that meditation might also alter expression of genes that are 
implicated in stress. 
The first study aiming to elucidate the effects of meditation on gene expression was 
done in 2005 by Li et al. (Q. Z. Li et al., 2005). Using a cross-sectional study design, 
the results suggested that genomic profiles changed in the practitioners of Falun 
Gong (an ancient Chinese practice of meditation). Since then other studies on the 
“epigenetics of meditation” have yielded similarly intriguing results. These are 
described in the literature review. 
Study aims 
The aim of this study was to determine firstly, whether meditation has any specific 
effects on the practitioner, and secondly whether there are differences between two 
different definitions of meditation, namely mental silence and body scan meditation 
(a mindfulness based technique). It was expected that both definitions of meditation 
are capable of invoking specific effects in the practitioner. These specific effects are 
thought to manifest as gene expression changes, which would be measured through 
microarray analysis. Additionally, it was also expected that both definitions of 
meditation would influence the expression of similar gene sets and particularly those 
that have been previously reported in the RCTs in the literature. 
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Literature Review 
Within the field of cell biology, the field of epigenetics has particularly broad 
potential to provide explanatory information about the impact of meditation on the 
body. While there are many reviews exploring the impact of meditation, or similar 
behavioural therapies, on physiology, health, behaviour and wellbeing there are 
considerably less studies, and hence less reviews, examining the biological 
mechanisms by which the purported health benefits of meditation might actually 
occur. This is particularly true of the mechanisms that operate at the level of cell 
biology and the genome.  
Currently, only one review examining studies of the impact of meditation on 
epigenetic factors has been published (Saatcioglu, 2013). In this review, Saatcioglu 
examined only 3 studies, each involving very different meditative practices: Qigong 
(Q. Z. Li et al., 2005), yoga (Sudarshan Kriya) (Sharma et al., 2008) and, in one 
study, a multitude of different meditative practices all thought to trigger the 
relaxation response (Dusek et al., 2008). These studies were diverse in their 
methodology, including cross-sectional studies, observational trials and controlled 
trials. So although this area of research is promising it is also clear that many more 
specific studies are needed to be done before there is conclusive understandings of 
what the exact influence that such interventions might have on the epigenome.  
In order to develop a more thorough understanding of the extant evidence concerning 
meditation and its influence on the epigenome I conducted a review of the literature. 
Since there is currently no consensus definition of meditation this review included 
any study purporting to assess any kind of meditation that is, no specific definition of 
meditation was selected. 
Computerised databases were searched, including: MEDLINE, PSYCINFO, 
EMBASE, Biological Reports, CINAHL, Web of Science and Scopus. In addition 
the general internet (Google) and paper searches were also examined. Keywords 
included: meditation, relaxation response, mindfulness, mbsr, transcendental, 
sudarshan kriya, sk, yoga, cognitive therapy, cbsm, falun gong, flg, kirtan kriya, 
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review, genetics, epigenetics, immune, telomerase, neutrophil, stress, transcription, 
inflammation. The search began in June 2013 and ended May 2015.  
Publications that assessed biological markers other than epigenetic changes, such as 
measuring cytokines, or antibody titres et cetera, were excluded because they are not 
direct measures of gene activity.  
The search yielded 10 articles; the details of which are summarised in Table 1. Of the 
10, 3 were RCTs, 2 were non-RCTs (Quasi experimental), 1 was an observational 
trial, 2 were cross-sectional and 2 were of a mixed nature comprising both 
observational trials and cross-sectional survey components. Sample sizes varied 
widely from as little as 12 participants to 199 participants. Interestingly, the studies, 
despite considerable variation in design and intervention, have a number of similar 
and common findings worth discussing. Importantly, due to the small number of 
studies, the generally small sample sizes and the wide variation in their methodology, 
a quantitative meta-analysis of the outcome data was not feasible. Although a 
descriptive review is the only assessment currently possible, since the current body 
of knowledge is so early in its development, this kind of review is still valuable as it 
will be useful for the development of further research in this area.  
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Table 1: Summary of studies looking at gene expression changes (FC) associated with meditation 
 
Trial design Intervention Period Sample 
Size 
Control Outcomes FC in Gene 
Expression 
RCT       
Black et al., 
2013 
Kirtan Kriya  8 weeks 45 Relaxing music Increased immunity/antiviral genes. 
Decreased NF-κB related genes 
> 1.2 
Creswell et al., 
2012 
Mindfulness Based 
Stress Reduction 
8 weeks 40 Waitlist Decreased NF-κB related genes 
and CRP 
>= 1.25 
Antoni et al., 
2012 
Cognitive Based 
Stress Management 
10 weeks 199 Psycho educational 
seminar 
Decreased NF-κB related genes  > 1.5 
Quasi Experimental (non RCT)      
Qu et al., 
2013 
Sudarshan Kriya & 
Related Practices 
2 days (2 
hrs each) 
14 Nature walk, jazz music Increased AVIL, NFE2 > 1 
Kaliman et al., 
2014 
Mindfulness 
Meditation 
1 day 40 Read, watch 
documentaries or play 
computer games & walk 
Downregulation of HDACs, COX2, 
RIPK2 
Uses adjusted 
differences & 
p < 0.05 
Observational Trial      
Ravnik-Glavac 
et al., 
2012 
Various Meditative 
Techniques 
N/A 2 N/A Immune function genes up & down 
regulated. Downregulation of DNA 
repair and metabolic processes 
>= 1.3 
Cross Sectional      
Sharma et al., 
2008 
Sudarshan Kriya N/A 84 Non-practitioners Increased hTERT, BCL2, PTGS2, 
HSP-70 
No cut-off, stat. 
sig. diff’s 
Li et al., 
2005  
Falun Gong N/A 12 Non-practitioners Decreased BCL2, ribosomal 
proteins, stress related genes. 
Increased HSP70 
> 2  
Mixed Design       
Bhasin et al., 
2013 
Relax’n Response 
Techniques 
8 weeks 52 Non-practitioners Decreased immune function genes, 
NF-κB related genes 
Not specified 
(p < 0.01) 
Dusek et al., 
2008 
Relax’n Response 
Techniques 
8 weeks 38 Non-practitioners Decreased immune function genes, 
NF-κB related genes 
Not specified 
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Cross-sectional studies 
The first study, by Li was published in 2005 (Q. Z. Li et al., 2005). It assessed a 
meditative practice known as Falun Gong (FLG) using a cross-sectional survey 
design. It compared 6 long-term FLG practitioners to 6 non-practitioners with no 
exposure to FLG. The study showed that practitioners had different gene expression 
profiles to their control counter parts. It reported significant gene changes in several 
different functional gene groups. Ubiquitin related genes were the first significant 
group which had the genes with the highest fold change. Of the 14 ubiquitin related 
genes identified, it was found that 13 were down regulated by more than two-fold. 
The second significant group of genes all coded for ribosomal related proteins. This 
group also had 13 out of 14 genes down regulated. The third group of genes were 
immunity related genes and of these 7 out of 8 were up regulated. Notable up-
regulated genes included IFNG, TYK2, PSK1 and OAS1. The down-regulated gene 
was KRT7. The final group of genes were stress and heat shock protein related. Out 
of the 15 genes, 13 were down regulated and they included notable genes such as 
GPX1, GST, AOC and ERCC1. The two down-regulated genes were heat shock 
proteins HSP70B and DNAJB5.  
In 2007 Sharma studied Sudarshan Kriya (SK) using the same study design as Li‟s 
FLG study and also found that it had an impact on gene activity (Sharma et al., 
2008). However, unlike Li‟s study, Sharma‟s study looked at a much narrower set of 
just 9 genes. Of the 9, there were significant changes in 3 genes: GSTP1 (glutathione 
S-transferase pi 1), HSP70 (heat shock protein 70) and PTGS2 (prostaglandin-
endoperoxide synthase 2) – all of which were found to be significantly higher in 
activity in SK practitioners compared to non-practitioners. HSP70 and PTGS2 have 
been found to be anti-apoptotic meaning that an increased expression of these genes 
may prolong immune cell life (Beere et al., 2000; Chang et al., 2000). GSTP1 codes 
for an enzyme involved in the metabolism of xenobiotics and therefore the 
detoxification of cells in the body, thus increased expression of this gene would be 
beneficial for overall health.  
The above two studies employed different measurement methodologies, each suited 
to the gene sample that they chose to target. Sharma‟s study used PCR to measure 
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changes for a relatively small set of specific genes relating to stress signalling 
pathways, antioxidants, DNA damage, cell cycle and apoptosis. Li‟s study was able 
to examine the impact of FLG on 12,000 genes through microarray analysis and 
confirm these findings with RNA protein assaying. Of these 12,000 genes it was 
found that 132 genes were down regulated and 118 genes up regulated in the 
practitioners of FLG compared to their respective controls. In contrast, Sharma‟s 
study measured gene expression via reverse transcriptase polymerase chain reaction, 
a different technique to detect RNA expression. Additional parameters that were also 
measured included superoxide dismutase activity and glutathione concentration 
which were both seen to be increased in SK practitioners.  
Coincidentally, there were two genes measured that are common to both studies – 
these were BCL2 and HSP70. BCL2 regulates programmed cell death and hence 
increased expression is thought to prevent premature cell death (Chao & Korsmeyer, 
1998). As mentioned previously, HSP70 codes for a heat shock protein which has 
similar anti-apoptotic properties via a different mechanism due to its critical 
involvement in assisting with proper folding and formation of proteins as well as the 
management of cell repair systems (Mayer & Bukau, 2005). Interestingly, Li reports 
that BCL2 was significantly reduced in response to FLG while Sharma reports the 
opposite, that is, BCL2 was increased slightly in response to Sudarshan Kriya. On 
the other hand, HSP70 changes moved in the same direction, of the same magnitude, 
in both studies. This discrepancy in outcomes is most likely due to the unreliable 
nature of cross-sectional design and various other methodological weaknesses in the 
two studies. For example, Li‟s study involved only 12 participants making it prone to 
type 2 errors (low statistical power). The two meditation techniques are very 
different and hence their biological effects could reflect this. The differing 
measurement methods (microarray vs PCR) may also introduce differences in the 
reliability of the outcomes. 
Cross-sectional studies are relatively quick and easy to conduct when compared to 
other study designs mainly because only one blood sample is required per participant 
thereby reducing both cost and labour. However the outcomes are prone to a number 
of confounding effects which reduce the reliability and generalisability of their 
findings. This is why cross-sectional studies, especially those with small sample 
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sizes, are at best pilot studies whose main value is to assist in hypothesis generation 
for larger more thorough and hence conclusive studies to be done. 
Observational trials 
Ravnik-Glavac et al. conducted an observational study in 2012 (Ravnik-Glavac, 
Hrasovec, Bon, Dreo, & Glavac, 2012). Unlike other studies which tested epigenetic 
changes after a meditation intervention, Ravnik-Glavac et al‟s study examined 
epigenetic changes invoked by a change to higher states of consciousness in two 
long-term meditators. Higher state of consciousness was defined as being in either 
one of several states as defined by ancient Vedic literature. The study found that 
although both meditators used different meditation practices to reach higher states of 
consciousness, a large number of genes were differentially regulated in both.  
The first meditator had been practicing for 23 years and used Zen and Kundalini 
meditation to experience higher states of consciousness, while the second meditator 
had 25 years of Buddhist meditation experience and used mental quietness and 
visualisations of Buddha to reach higher states of consciousness.  
After taking whole blood samples from both meditators before and after they had 
entered a higher state of consciousness (it was unclear as to how the switch to a 
higher state of consciousness was determined) RNA was extracted, protected and 
analysed using RNA stabilisation and microarray technology. To confirm the results 
obtained from the microarray analysis, real-time quantitative PCR was performed. 
Overall 1668 unique genes were changed in meditator 1 and 608 unique genes 
changed in meditator 2.  
Gene ontology analysis revealed that the meditator using Zen and Kundalini yoga 
had significant down regulation of genes relating to cotranslational protein targeting 
to membrane, mRNA processing, RNA splicing, RNA binding, protein serine 
activity, ubiquitin protein ligase activity, Golgi apparatus, centrosome and endosome 
proteins. Significantly up-regulated were genes involved in: erythrocyte 
maturation/development, induction of positive chemotaxis, haemoglobin metabolism, 
haemoglobin binding, anion exchanger activity, oxygen transporter activity, the 
cytosol, the nuclear inner membrane and the autophagic vacuole. 
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On the other hand, achieving a higher state of consciousness via mental quietness 
and visualisations of Buddha, resulted in significant down regulation of genes related 
to: regulation of cellular processes, regulation of biological process, biological 
regulation, protein binding, phosphatase binding, transcription factor binding, the cell 
cortex, the stereocilium, the nuclear speck and cell projection genes. The up-
regulated categories included: glycerol metabolic process, alditol metabolic process, 
regulation of lipid catabolic process, structural constituent of ribosome, nuclease 
activity, racemase and epimerase activity, intracellular membrane bounded organelle, 
organellar ribosome, voltage gated potassium channel complex, cilium, 
mitochondrial respiratory chain complex 1 and VLDL particle genes. 
The significant disparity in the type and number of genes differentially regulated 
between both meditators may be explained by a number of factors. Unlike Sharma‟s 
study which looked at a comparatively smaller set of genes, Ravnik-Glavac et al. 
looked at a genome-wide change. The genome-wide analysis showed that 
Zen/Kundalini yoga was able to invoke a larger number of genetic changes than 
compared to Buddhist meditation. The importance of this outcome is that it suggests 
different meditations may have a varying degree of genetic impact, maybe even 
through different mechanisms.  
The sample size of two and the lack of a control group clearly limit the 
generalisability of the findings. Large sample sizes and control groups are essential 
in attaining precise results in observational studies. Although the study does lack the 
appropriate sample size and control group, it raises the possibility that different 
practices of meditation may have different underlying mechanisms allowing each of 
them to invoke genetic changes to varying degrees of significance. Conversely, it 
may be possible that these gene expression changes are attributable to the unique 
nature of these two individuals and hence these changes may be invisible in the 
wider population.  
Mixed study designs 
Following research conducted by Sharma et al. and Li et al. a 2008 study by Dusek et 
al. utilised a slightly more advanced study design involving an observational trial and 
cross-sectional survey component (Dusek et al., 2008). The basis of the study 
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revolved around previously observed physiological changes in long-term 
practitioners of relaxation response invoking techniques such as, various forms of 
meditation, repetitive prayer, yoga and breathing exercises. This study further 
established preliminary evidence that relaxation response techniques can illicit 
epigenetic changes in the long term, however the authors decided to follow this up by 
determining if relaxation response techniques could invoke any short-term epigenetic 
changes in a second study (Bhasin et al., 2013). The second study uses the same 
hybrid study design but instead measured genetic changes over 3 time points: before 
the intervention, immediately after and 15 minutes after. For easier analysis both 
studies use Expression Analysis Systematic Explorer analysis to group the vast 
number of differentially expressed genes into biological themes (gene ontology 
categories) allowing for a discussion on what physiological changes may have 
occurred.  
Dusek et al‟s 2008 study used a sample size of 38, while Bhasin et al‟s 2013 study 
used a larger sample size of 52, however without the inclusion of a required sample 
size estimation; it is hard to tell if these sample sizes were chosen arbitrarily or via a 
calculation. Nevertheless, participants had their blood samples drawn before and 
after the intervention for microarray analysis.  
Dusek et al‟s study revealed 2209 statistically significant genes were differentially 
expressed when comparing long-term practitioners to their non-practicing 
counterparts. Of these genes, 1275 were up regulated and 934 down regulated. When 
comparing samples of the novices before and after the 8 week period, it was shown 
that 1561 genes were differentially expressed and of these 874 were up regulated and 
687 were down regulated. Gene ontology categories which had effected genes were 
oxidative phosphorylation, ubiquitin-dependent protein catabolism, mRNA splicing, 
ribosomes, metabolic processes, regulation of apoptosis, NF-κB pathways, cysteine 
type endopeptidase activity and antigen processing.  
Bhasin et al‟s study produced further supporting evidence showing that both short-
term and long-term practitioners have altered gene profiles immediately after the 
intervention when compared to novices, with a more significant change occurring in 
the long-term practitioners. Progressively up-regulated genes belonged to the 
following categories: regulation of cell differentiation, cell adhesion, cell 
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communication and transport, hormone stimulus, blood pressure, cAMP, metabolic 
processes, biological oxidation and oxidoreductase activity. On the other hand, 
down-regulated genes belonged to the categories: mRNA processing, intracellular 
protein transport, antigen processing and presentation, immune system and primary 
metabolism. Genes which were differentially expressed in long-term practitioners 
when compared to their novice counterparts both before and after the 8 weeks 
intervention were described as being long-term up or down regulated. The up-
regulated genes belonged to the following categories: ATP activity, protein binding, 
cell adhesion, defence response, amine transport, response to stress, gap junction and 
muscle cell differentiation. Down-regulated long-term genes were included in these 
categories: regulation apoptosis, nuclear transport, metabolic processes, JAK STAT 
cascade, T and B cell activation, regulation of cell cycle, insulin sensitivity, glucose 
transport, DNA replication, chemokine signalling, EGF signalling and stress 
response.  
Both studies aimed to increase their validity by combining observational and cross-
sectional study design components, however the lack of an active control and the 
varied methods of activating the relaxation response meant that non-specific effects 
could not be ruled out. This may also be able to explain why Ravnik-Glavac et al‟s 
study showed an up regulation of genes relating to immune function while Bhasin et 
al. and Dusek et al. found the opposite. Despite this, it is interesting to note that when 
comparing the results of both Bhasin et al. and Dusek et al‟s studies to Ravnik-
Glavac et al‟s observational trial a common trend emerges. Genes regulating the NF-
κB pathway are observed to be down regulated in all 3 studies, regardless of what 
meditation technique or study design was used.  
It is noteworthy that recent studies have found that chronic psychological stress and 
psychiatric illness can lead to the activation of the NF-κB pathway resulting in a 
large number of pro-inflammatory genes being transcribed (Bierhaus, Humpert, & 
Nawroth, 2004; Miller et al., 2008; T. W. Pace et al., 2012). Hence it is only logical 
to conclude that meditation may be able to reverse inflammatory responses induced 
by external stressors, psychological or otherwise.  
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Repeated measures designs (non-RCT) 
In 2013 Qu et al. published the first repeated measures design study (a type of non-
randomised control trial) which furthered the notion that Sudarshan Kriya and its 
related practices (SK&P) have epigenetic impacts (Qu et al., 2013). Similar to 
Sharma‟s study, it revealed that a large number of key genes were up or down 
regulated in the meditators and which may be linked to beneficial health effects. 
The participants were all originally attending a 7-day yoga retreat in Oppenau 
Germany when they were recruited to the 4-day study via an announcement on the 
first day of the retreat. All participants were current practitioners of SK&P and had 
been practicing for 1.5 to 5 years. The inclusion criterion was: male, 18–50 years of 
age, no chronic disease and good psychological health as determined by a GHQ28 
questionnaire. Only 14 participants ended up participating, of which 4 missed a 
session or could not donate enough blood. On days 1 and 2 all participants practiced 
SK&P while giving blood samples before and after the daily sessions. On days 3 and 
4 participants undertook a nature walk which served as the control activity. In this 
design, there was no separate control group.  
It was found that SK&P altered 111 genes while nature walking altered only 38, of 
which 14 were common in both groups. The 9 most significant genes which were 
regulated by SK&P only included: NFE2, RAB24, AVIL, PFKFB3, EXT1, MMP28, 
CCR7, CEACAM1 and SIPA1L2. NFE2 codes for a protein which is responsible for 
erythroid and megakaryocytic maturation and differentiation which may mean it is 
beneficial in increasing immune function (Andrews, 1998). It was significantly up 
regulated after SK&P. This is a surprising result as noted before, Bhasin et al. and 
Dusek et al‟s studies revealed that immune function genes were down regulated (as 
would be expected of a mechanism of reducing inflammation). The other significant 
finding was the increased expression of AVIL which codes for a protein called 
advillin. Advillin is involved in the repair of neuronal cells in neonates and also 
ciliogenesis which enhances cell signalling and development (Marks, Arai, Bandura, 
& Kwiatkowski, 1998). On the other hand, the 7 most significant genes which were 
regulated by nature walking included RN7SK, SLC36A, FKBP5, IL7R, PIP3, CHN1 
and ANKRD9. In general these genes do not directly pose any positive or negative 
effects on physiological systems; however they may affect other unknown pathways.  
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Repeated measure design studies are mainly designed for efficiency and convenience 
as the analysis strategy attempts to compensate for the absence of a control group 
and a smaller sample size. Most repeated measures study designs are prone to the 
“practice effect” which results in the participants becoming fatigued, or overfamiliar 
with the tests and unwilling to genuinely participate in the study. Qu et al. have 
minimised this effect by only running each intervention for only 2 days each, while 
also recruiting motivated participants from a yoga retreat. Overall this study design is 
superior to all other designs and is only exceeded in methodological hierarchy by 
randomised controlled trials.  
Quasi experimental (non-RCT) 
In 2014, Kaliman et al. conducted a quasi-experimental trial aimed at determining 
mindfulness meditation and related practices‟ effect on inflammatory gene 
expression and also histone deacetylases (Kaliman et al., 2014). Decreased pro-
inflammatory gene expression was found in the mindfulness meditation group. This 
study was also the first to specifically look at gene expression changes in histone 
deacetylases (HDACs), histone methyltransferases and demethylases which are all 
enzymes involved in chromatin epigenetic modifications. Overall the results 
provided an additional basis for us to hypothesis on the epigenetic mechanism by 
which meditation exerts its therapeutic effects.  
The study consisted of 19 long-term meditators and 21 control subjects who had no 
previous exposure to meditation. The meditators were recruited at meditation centres 
throughout the US and also via mailing lists, newspaper articles and flyers. Inclusion 
criteria for the meditators included having at least 3 years of daily meditation 
practice, with a minimum of 30 minutes of meditation per day and also the 
attendance of at least 3 intensive retreats lasting 5 hours or more. Meditators came 
from a mixed background of both mindfulness based meditations and compassion-
related meditations (as per Tibetan and Theravada Buddhist traditions). The control 
group was recruited via local advertisements which advertised the study as a non-
pharmacological intervention designed to promote wellbeing.  
The results of the study showed that in the mindfulness group, two inflammatory 
genes were down-regulated by a significant amount (PTGS2 and RIPK2). Other 
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genes which were suspected to be effected such as CCR7, CXCR1, TNFA and IL6 
were shown to have no significant difference between groups after PCR analysis. 
The meditation showed a decrease in HDAC2, HDAC3 and HDAC9 gene expression 
when compared to controls.  
Although the study demonstrated that mindfulness meditation may incur changes at 
the genetic level, the study‟s lack of randomisation and active controls leaves some 
doubt as to the validity of the results. Interestingly, as opposed to previous studies 
mentioned before, Kaliman et al. failed to observe any significant differences in two 
key pro-inflammatory genes that is, TNFA and IL6.  
Randomised controlled trials 
RCTs are considered the gold standard of clinical trials as they can detect the effect 
of the intervention without the differences between groups being attributable to 
external factors. Hence, when compared to the other study designs, RCTs are far 
more superior in terms of internal and external validity.  
Only 3 RCTs concerning meditation and genetic effects were found (Antoni et al., 
2012; D. S. Black et al., 2013; Creswell et al., 2012). They involved cancer patients, 
dementia caregivers and lonely adults all of whom had been experiencing high levels 
of stress and anxiety.  
These RCTs are significant as they confirm results from previous less 
methodologically sound study designs. All 3 studies reported decreased gene 
expression relating to pro-inflammatory pathways and 2 of the 3 studies observed 
increases in immunity related gene expression (Antoni et al., 2012; D. S. Black et al., 
2013). 
Two studies used active controls thus eliminating non-specific effects (Antoni et al., 
2012; D. S. Black et al., 2013). In Black et al‟s study there were 45 participants who 
were divided into the intervention (SK&P) and the active control group which 
listened to relaxing music for 12 minutes, while in Antoni et al‟s study, which had 
199 participants, the control group had to attend an educational seminar on 
mindfulness based stress reduction (MBSR) and its purported effects. The third study 
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by Creswell et al. consisted of 40 participants and used a waitlist control (Creswell et 
al., 2012).  
Antoni et al‟s results included 91 differentially expressed genes in CBSM 
participants of which 62 were down regulated and 29 were up regulated. A gene 
ontology analysis revealed that the genes encoding for pro-inflammatory cytokines 
IL1A, IL1B and IL6, were amongst the most significantly reduced. Prostaglandin 
synthesis enzymes were the second most significantly reduced followed by 
inflammatory chemokines and receptors. These key down-regulated genes are linked 
with NF-κB signalling pathways. Although genes coding for mediators of tissue 
remodelling and epithelial mesenchymal transition were significantly reduced, the 
biological implications are unclear. Type 1 interferon response genes, type 2 
interferon signalling and interferon signal transduction genes were the most 
significantly increased, all of which enhance antiviral responses.  
Similarly Black et al‟s study revealed 68 differentially expressed genes of which 49 
were down regulated and 19 up regulated. Immune function related genes were the 
most relevant to be up regulated and included IGJ and IGLL3. There were also many 
genes which were up regulated that had unknown functions. Pro-inflammatory 
cytokines and activation related immediate early genes were the most significantly 
down regulated. These categories included genes such as IL8, FOSB, IL6 and JUN.  
Creswell et al. identified 256 differentially expressed genes of which 69 were down 
regulated and 74 up regulated. Although the number of differentially expressed genes 
was more than double that of the other two RCTs, ontology and pathway analysis 
revealed that the MBSR affected the transcriptional factor activity of the NF-κB 
pathway in a similar fashion to SK&P and MBSR.  
Overall all the 3 RCTs identified similar genes were either up regulated or down 
regulated by 3 different meditation related practices, suggesting that they all work via 
a similar biological mechanism. When comparing the results of these RCTs to the 
other inferior study designs, it can be seen that the overall results seemed to be very 
similar.  
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Summary 
The review demonstrates that meditation and its related practices do appear to have 
epigenetic impacts, hence giving us good reason to investigate the biological 
mechanism by which meditation can exert its purported effects.  
The most significant group of genes were pro-inflammatory mediators that are linked 
to the NF-κB pathway which is involved in the inflammatory stress response 
(Mercurio & Manning, 1999). In 5 of the 10 studies, genes coding for pro-
inflammatory mediators were down regulated significantly. These studies included 
several types of meditation practices, yoga and repetitive prayer (Bhasin et al., 2013; 
D. S. Black et al., 2013; Creswell et al., 2012; Dusek et al., 2008).  
A 2007 review highlighted that psychological stress induces inflammation through 
the actions of pro-inflammatory mediators which are under the regulation of the NF-
κB pathway (A. Steptoe, M. Hamer, & Y. Chida, 2007). Furthermore, it has been 
well established that a range of psychiatric illnesses, specifically clinical depression, 
have been linked with the chronic inflammatory state (Dantzer, O'Connor, Freund, 
Johnson, & Kelley, 2008; Kivimaki et al., 2014; Krishnadas & Cavanagh, 2012). The 
current evidence that meditation and related practices decrease the expression of 
genes relating to the NF-κB pathway highlights its potential as a treatment for 
psychiatric illnesses and also as a method of promoting general wellbeing.  
Study design plays a major role in determining the validity of the results. Overall 
there were only 3 RCTs. None of these RCTs used controls that adequately 
controlled for placebo. In fact, the control methods varied considerably between 
studies as did the interventions themselves making inter-trial comparison and 
generalisation difficult. Despite these important methodological shortcomings, they 
all reported decreased inflammatory related gene activity. Although the other studies 
had similar results, flaws in their methodology meant that the validity of results were 
questionable.  
A randomised controlled trial comparing two different definitions of meditation 
would therefore be the next step in the development of knowledge about the 
epigenetic impacts of meditation and could also be a significant contribution to the 
literature. By comparing two different definitions of meditation the need to control 
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for non-specific effects would be fulfilled by providing participants with a plausible 
control regimen.  
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Methods 
Study design 
The study was designed to compare the mental stillness approach of meditation with 
another meditation exercise, mindfullness (which is not of the non-mental stillness 
type). A randomised, double-blind, parallel-group, controlled trial design was 
adopted. Participants were recruited over a period of 1 month and randomly allocated 
into either the mental stillness meditation or the mindfulness group. Both groups 
required participants to attend a weekly 1 hour supervised session and also to 
practice the techniques at home on a daily basis. Participants were briefed before the 
commencement of the trial and advised that the trial aimed to compare the genetic 
changes evoked by 2 different types of meditations. Blood was taken prior to 
commencing the trial and again after the 4-week period had elapsed. Based on 
previous studies which used a wait list control, a RCT comparing two definitions of 
meditation would be superior to a wait list control group which has a couple of 
disadvantages. A disadvantage of waitlist control groups is that any gene expression 
changes that occur in the mental silence meditation group may be attributed to them 
receiving a greater clinical attention than those simply waiting in the control group. 
A 2013 study proved that wait list control groups may artificially inflate the effect of 
the intervention group (Cunningham, Kypri, & McCambridge, 2013). Additionally, 
participant wait time must also be considered. For example, longer wait times may 
cause participants to lose interest in the study and may result in increased dropout 
rates. The clinical trial protocol was approved by the Human Research Ethics 
Committee of the University of Sydney (protocol number: 2013/953).  
Participants 
Eligibility criteria for participants involved in the study included: 
• no previous exposure to meditation a study 
• no major physical or mental illness 
• aged between 18–30 years 
• non-smoker 
• prepared to not drink alcohol for the duration of the study 
 42 
• prepared to attend a 1 hour weekly session at a given location 
• prepared to meditate twice daily at home 
• prepared to fill out questionnaires 
• prepared to keep a compliance diary 
• prepared to give blood twice  
Exclusion criteria for participants involved in the study included: 
• major medical illness present 
• have had or currently have a mental illness 
• currently on medication 
• no current consumption of alcohol, tobacco or illicit drugs.  
Participants were recruited using flyers which were put up around the University of 
Sydney campus and local libraries in the surrounding area. Additionally, recruitment 
was also done via social media (Facebook) and word of mouth.  
Randomisation, blinding and controlling for non-
specific effects 
Randomisation was performed by a research assistant, in the absence of the chief 
investigators, using a blindfolded lottery allocation system. Participants were then 
informed of their allocation at the briefing prior to the first session. This allocation 
was not disclosed to either of the chief investigators.  
Participants were blinded to the complete hypothesis of the clinical trial and were not 
informed as to which methods of meditation were being used in the alternative 
group. They were instructed not to disclose any information regarding activities done 
in their groups to those in the comparison group. Data entry personnel, blood 
collection personnel, scorers and statisticians were also blinded to group allocation.  
The two meditation interventions were structured identically so that non-specific 
factors such as credibility, expectation and demand characteristics were matched as 
closely as possible: Classes for both intervention groups were conducted in similar 
rooms, at approximately the same time of day, with similar support materials; 
instructional sessions were of equal duration with equivalent periods between 
interventions. 
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Interventions 
The intervention period was 4 weeks, and involved 1 hour instructed sessions held 
weekly. Additionally participants were requested to practice the same technique at 
home twice daily for 10–15 minutes each time. Instructors for both groups were 
qualified meditation instructors and also health professionals.  
The first group was instructed on how to enter a state of mental silence through the 
use of a series of silent psychological affirmations while sitting on a chair (see 
Appendix 2 – Mental Silence Meditation). These sessions were focused on helping 
the participants achieve mental silence and participants were encouraged to ask for 
assistance if they had any difficulty achieving this state of mind. Participants were 
each given a resource bag which included a CD with meditative music and the 
affirmations and also a book on the mental silence experience. They were advised to 
use these resources to perform the same mental silence exercises at home for 10–15 
minutes twice a day. At the beginning of each session compliance diaries were 
collected (see Appendix 3 – Participant Survey Form & Diaries), and at the end of 
each session food and drink were provided.  
The second group was structured in a similar manner to replicate the interventions as 
closely as possible. The sessions were held in a community centre at the same time 
as the other group. This group was taught a mindfulness based exercise known as 
“body scan meditation” which was delivered by a guided audio CD. The guided 
meditation was downloaded from the University of Vermont‟s “The Centre for 
Health & Wellbeing” website and went for approximately 20 minutes. Participants 
were given this CD to take home and asked to practice the same technique at home 
twice a day for 10–15 minutes. Additionally, participants were given a handout 
which described the “body scan meditation” and its effects (see Appendix 1 – Body 
Scan Meditation). At the end of each of the weekly sessions, participants were also 
offered food and drink. The key difference between the two groups was that one 
form of meditation featured mental silence, while the other did not.  
Measures 
Baseline assessments were done prior to commencing the first session. All 
participants were invited to the same location and a briefing was held outlining the 
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study and what was expected from each participant. Participants were then asked to 
fill out the baseline questionnaire battery which also included consent and contact 
information forms (see Appendix 3 – Participant Survey Form & Diaries). All 
questions and difficulties were directed to the medical and meditation staff present at 
the briefing. Following this, participants were then advised of their allocation and 
then told to either stay or make their way to the alternate venue based on what they 
had been allocated. At the end of the 4 weeks the same baseline questionnaires were 
filled out.  
Diaries 
Participants were given a 4-week diary at the briefing and were advised to fill this 
out every day until they came to the next session at which the instructor would 
collect the diary (see Appendix 3 – Participant Survey Form & Diaries). Recorded 
information included: how many times did you meditate per day, did you do a foot 
soak (for the mental silence group only), overall level of mental silence during 
morning meditation, overall level of mental silence during evening meditation and 
also overall mood for the day.  
Collection of whole blood 
Blood sample collection took place at two time points, one before the 
commencement of the trial and one after the last session of the trial. Doctors and 
nurses carried out the extraction of whole blood from participants using a winged 
infusion set to draw 6 mL of blood directly into vacuette Tempus Blood RNA tubes 
which contained a RNA stabilisation solution). The blood tubes were then taken to a 
fridge for an overnight stay at 4ºC and then moved to a −20ºC freezer until processed 
as per the manufacturer‟s directions (Tempus™ Blood RNA Tube, 
Affymetrix/Thermo Fischer scientific protocol) (Aarem et al., 2016; Häntzsch et al., 
2014).  
Compliance 
Diaries were collected at the start of each session to mark attendance. Compliance 
during the week was assessed via the diaries that they were asked to fill out every 
day.  
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Gene arrays 
The Affymetrix Human Genome U219 array plate contains over 530,000 probes 
which cover approximately 36,000 transcripts and variants, in turn representing over 
20,000 genes mapped through Unigene (www.ncbi.nlm.nih.gov/unigene) and RefSeq 
annotation (http://www-ncbi-nlm-nih-gov.ezproxy1.library.usyd.edu.au/RefSeq/) . 
The U219 array plate is able to process up to 96 samples simultaneously, making it 
ideal to compare gene expression profiles in the current 50 sample sized study 
(Affymetrix, Santa Clara, CA, USA). 
Gene arrays are able to generate thousands of data points per sample making it 
difficult to identify relevant information and hence specialised software is used to 
analyse this vast amount of data. The Partek Genomics Suite was used as it can 
perform advanced statistical analysis, such as ANOVA, on the raw data files 
obtained from the gene array chips while also providing a visual representation of the 
data via heatmaps and principal component analysis plots (Balding, Bishop, & 
Cannings, 2008). The analysis for this paper was generated using Partek® software 
(copyright, Partek Inc. Partek and all other Partek Inc. product or service names are 
registered trademarks or trademarks of Partek Inc., St. Louis, MO, USA.).  
RNA extraction from whole blood 
Whole blood RNA was extracted from the whole blood using the Tempus Spin RNA 
Isolation kit as per the manufacturer‟s directions (Tempus™ Blood RNA Tube, 
Affymetrix/Thermo Fischer scientific protocol). The extracted RNA was verified for 
its quality and quantity using the NanoDropTM 1000 Spectrophotometer (NanoDrop 
Technologies, Berlin, Germany) and Agilent 2001 Bioanalyser analysis (Agilent 
Technologies, Waldbronn, Germany) (acceptable RNA integrity numbers between 
6.0–10.0) (Valletti et al., 2013). The quality of the RNA was assessed by a modified 
agarose gel electrophoresis method which involved detection from the Agilent 2001 
Bioanalyser. After confirming the sample quality and quantitiy , the RNA samples 
were stored at −80ºC until required for processing.  
RNA sample submission for analysis 
The Affymetrix Human Genome U219 array plate was used for the microarray 
analysis. Total RNA, 500 ng per sample, was submitted to the Ramaciotti Centre for 
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Genomics (University of New South Wales, Sydney), at which the target preparation, 
array washing, staining and analysis was carried out. Overall 50 RNA samples were 
submitted for the analysis.  
Microarray data analysis 
Raw expression values from the Affymetrix Genechip operating software (GCOS) 
were obtained as CEL files. These were then opened using the Partek Genomic Suite 
6.6 software (Partek Inc). All samples were checked for quality and they all 
demonstrated characteristics of high quality cRNA (3'/5' threshold ratio of probe sets 
for the integral housekeeping genes of 1.5). The raw data were normalised using the 
robust multichip averaging algorithm which retains probe-level information and 
applies probe-specific background correction, compensating for any non-specific 
binding found in the gene chips using the perfect-match probe distribution (Rafael A. 
Irizarry et al., 2003).  
In addition, robust multichip averaging normalisation applied perfect-match 
distributions across all the chips and a robust probe-set summary of the normalised 
probe-level data by median polishing was obtained (Beyer, 1981). Array data quality 
was confirmed by principal component analysis, which examined correlation 
between the data derived from the different arrays and identified potential outliers 
(R. A. Irizarry et al., 2003; Ringner, 2008). The analysis of variance (ANOVA) with 
a nominal alpha value set to 0.05 was then used to determine those probe sets 
significantly different between the mental silence meditation group and the active 
control meditation group within each time point (before and after) and separately 
across both time points. This was followed by a Benjamini and Hochberg multiple 
testing correction, controlled at 5%, to reduce the false positive rate (Noble, 2009). 
To ensure the accuracy of the results, only differentially expressed genes with a false 
discovery rate less than or equal to 0.05 and a fold change (FC, how many fold 
increase/decrease in gene expression levels) greater than or equal to 1.4 were further 
analysed.  
Gene lists were prepared from each comparison group and identification of cellular 
functions of differentially regulated genes was achieved utilising the Partek pathway 
analysis tool as well as online bioinformatics tools including the Ingenuity®Systems 
Pathway Analysis (Ingenuity Systems, http://www.ingenuity.com). This allowed 
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identification of interrelationships of the individual groups in a network format and 
analysis of genes in the context of functional groups rather than as singular entities, 
making it easier to highlight potential mechanisms underlying the mental stillness 
meditation in comparison to body scan meditation. A functional analysis was 
performed using differentially expressed genes in order to categorise them into bio-
functions and pathways. The significance of the relationship to a bio-functional 
category or pathway was calculated by the taking the ratio of the total number of 
genes or molecules from the dataset and the total number of genes or molecules from 
the function. Significance was also calculated by a right-tailed Fisher‟s exact test 
with p values of less than 0.05 being deemed significant (R. A. Irizarry et al., 2003).  
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Results 
It is generally well accepted that clinical trials should have a minimum of 30 
participants per treatment arm. However, due to the exploratory nature of this study it 
was deemed acceptable to aim for a total sample size of 50 (with 25 in each 
treatment arm). Overall, 50 participants were recruited. Of these, there were 2 drop 
outs which resulted in 24 participants remaining in each intervention group. All of 
the 48 participants complied and completed the full intervention period.  
Gene array results 
Within group changes 
The principal component analysis showed a significant separation between the 
samples within each group, indicating that the quality of the microarray data was 
acceptable. The pathways analysis did not reveal any significant results and thus was 
omitted.  
Overall, 16 genes were changed in the meditation group when comparing blood 
samples from before and after the intervention period. On the other hand, 48 genes 
were changed in the control group when comparing blood samples from before and 
after the intervention period. Genes of interest were selected according to the 
specified criteria that they showed a fold change > 1.4 and p value ≤ 0.05. The fold 
change was defined as the quantity of change based on the before the intervention 
compared to after intervention time points. As shown in Table 2, in the meditation 
group, 16 unique genes (10 down regulated and 6 up regulated) were changed after 
the intervention period. While in the control group, as shown in Table 3, 51 unique 
genes (47 down regulated and 4 up regulated) were changed after the intervention 
period. Two genes was significantly changed and were common to both the mental 
silence and the body scan groups. These genes were HIRA and INPP4B. HIRA 
encodes a histone chaperone, which is preferential in placing the H3.3 variant in 
nucleosomes, and thus involved in cell senescence. INPP4B encodes an enzyme 
involved in phosphatidylinositol signalling pathways. HIRA was up regulated by 
1.80 FC in the mental silence group and 1.55 FC in the body scan group. Conversely 
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INPP4B was down regulated in the mental silence group by −1.86 FC and −2.32 FC 
in the body scan group.  
 
Table 2: Significant gene changes observed in the mental silence group 
Gene FC* P value Probe set ID 
IGHG3 3.03 0.036 11761467_x_at 
KIAA0101 2.01 0.007 11744425_a_at 
HIRA 1.80 0.003 11720837_a_at 
LMAN1 1.80 0.004 11747181_a_at 
CLEC10A 1.60 0.023 11745500_a_at 
TNKS2 1.52 0.009 11722462_a_at 
WDFY1 -1.50 0.014 11754884_s_at 
MBNL1 -1.52 0.020 11744794_a_at 
SMARCA2 -1.57 0.017 11743340_a_at 
PLXNC1 -1.59 0.041 11736207_a_at 
CD84 -1.60 0.044 11746087_a_at 
PNISR -1.66 0.001 11759600_at 
OSBPL8 -1.68 0.041 11718643_a_at 
INPP4B -1.71 0.010 11739840_a_at 
TBL1X -1.86 0.001 11740214_a_at 
NOTCH2NL -1.92 0.016 11719212_a_at 
* Mean fold change in gene expression. 
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Table 3: Significant gene changes observed in the body scan group 
Gene FC* P value Probe set ID 
TRIM49D2 1.81 0.007 11735772_s_at 
RAB2B 1.61 0.000 11744458_a_at 
HIRA 1.55 0.035 11720837_a_at 
KLHL18 1.51 0.005 11749153_a_at 
PARN -1.50 0.002 11750729_a_at 
RNF145 -1.50 0.008 11747975_x_at 
TRIB2 -1.51 0.044 11716940_a_at 
RIOK1 -1.51 0.024 11733924_a_at 
CLSTN1 -1.52 0.006 11715572_a_at 
ETF1 -1.52 0.003 11721449_a_at 
CHD4 -1.52 0.006 11743463_a_at 
ITGA4 -1.53 0.028 11746767_a_at 
CD3G -1.54 0.045 11731764_a_at 
SLC25A36 -1.54 0.026 11717498_a_at 
AKAP11 -1.54 0.006 11763810_a_at 
CLK4 -1.54 0.043 11759932_at 
RNGTT -1.55 0.010 11721329_a_at 
CAMSAP1 -1.55 0.029 11720416_a_at 
MAN1A1 -1.55 0.002 11752500_a_at 
USP34 -1.57 0.014 11723681_a_at 
ZSWIM6 -1.57 0.007 11744133_s_at 
TAF15 -1.57 0.038 11750911_x_at 
DYNC1H1 -1.57 0.035 11715589_at 
ZNF800 -1.57 0.007 11759779_at 
ETS1 -1.57 0.042 11722301_a_at 
GNPNAT1 -1.58 0.005 11758604_x_at 
ZKSCAN1 -1.60 0.026 11754860_a_at 
TTC3 -1.61 0.026 11715641_a_at 
ZNF644 -1.63 0.026 11758209_s_at 
PARP14 -1.63 0.022 11749412_a_at 
BRWD1 -1.65 0.001 11728439_at 
PCDH9 -1.67 0.010 11745210_s_at 
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Gene FC* P value Probe set ID 
ITCH -1.68 0.027 11745275_x_at 
BCLAF1 -1.68 0.002 11728219_a_at 
RAD23B -1.70 0.006 11745264_a_at 
TMEM106B -1.71 0.041 11721215_a_at 
CTDSPL2 -1.71 0.005 11730816_a_at 
P2RY13 -1.73 0.016 11731729_at 
ARHGEF3 -1.74 0.025 11723491_a_at 
KCNA3 -1.78 0.029 11731917_at 
EZR -1.83 0.023 11742990_x_at 
CD44 -1.88 0.034 11715915_a_at 
UFL1 -1.90 0.003 11751145_a_at 
PRKD3 -1.92 0.002 11739583_s_at 
UBXN4 -2.09 0.004 11751000_a_at 
TMEM260 -2.19 0.003 11727474_a_at 
INPP4B -2.32 0.001 11739840_a_at 
PTPRC -2.59 0.001 11733344_at 
* Fold change in gene expression. 
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Discussion 
The first and most obvious observation arising from this study is that the two 
interventions have activated two very different sets of genes, suggesting that the 
impacts of the two interventions may have different biological consequences. At the 
inception of this project, our expectation was that the two interventions would 
probably be associated with changes in similar sets of genes as both interventions 
were „meditation‟ techniques. We expected that differences, if any, might be seen in 
the extent or possibly the direction in which those up or down regulations might 
occur.   
An important question that arises from this is whether or not these differential gene 
changes are beneficial, detrimental or neutral in their impact on the practitioner. 
Isolated changes in gene function clearly can be understood in many different ways. 
Although it is important to avoid over-interpretation of these changes, for the sake of 
discussion, I have attempted to examine each of the changes in the genes, and based 
on published research into these genes explore what impacts those gene functions 
might have on the whole person. Gene functions were obtained through either 
National Center for Biotechnology Information, US National Library of Medicine‟s 
gene database (http://www.ncbi.nlm.nih.gov/gene) or through the UniProtKB 
(http://www.uniprot.org/). 
If the understanding of the genes in the current peer-reviewed literature is a fair 
representation of the function of these genes and their overall impact on the 
practitioner, then one can argue that the pattern of gene changes in the mental silence 
group could be understood as potentially generally beneficial. However, the gene 
changes observed in the body scan group (which used a mindfulness based 
technique), based on the understanding of these genes in the peer-reviewed literature 
there is no clear pattern of benefit and in fact it can be argued that several of the gene 
changes might be detrimental to the practitioner.  
We must address the dilemma of selecting an appropriate fold change cut-off for the 
gene expression changes. In general amongst the scientific community, larger 
powered genetic studies are considered as respectable with fold change values of 
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greater than 2 (with p < 0.05). As gene expression studies on meditation are still in 
their early stages they can be classified as being exploratory. As the description 
suggests, exploratory research aims to identify any subtle changes that may occur as 
a result of the intervention. As meditation may only evoke subtle gene expression 
changes, it is crucial for lesser fold change cut-offs to be used. This reduces the 
chances of type 1 errors therefore maximising our chances of identifying a specific 
effect.  
The studies identified in my literature review vary in the value of the fold change 
cut-offs used. Of the 10 studies (see data in Table 1): 
• 1 study used a fold change cut-off of > 2 
• 1 study used a fold change cut-off of > 1.5 
• 1 study used a fold change cut-off of >= 1.3 
• 1 study used a fold change cut-off of >= 1.25 
• 1 study used a fold change cut-off of > 1.2 
• 1 study used a fold change cut-off of > 1 
• 2 studies did not specify their cut-offs 
• 1 study used adjusted differences with a p < 0.05. 
My study took a modest approach and employed a fold change cut-off of > 1.4 
The implications of the observed gene expression 
changes 
The gene groups altered in both groups provide us with some insights into the 
possible biological mechanism by which meditation practices exert their clinical 
effects. 
These findings are all the more intriguing because they contradicted our 
expectations. Throughout the planning and execution of the study we expected that 
the two interventions groups would bring about changes in activity in similar gene 
groups. We anticipated that the main difference between the groups would be the 
degree to which the gene groups were up or down regulated. So we were surprised to 
find that the two interventions, despite both being described as “meditation”, were 
associated with very different patterns of gene activity change. So much so that in 
fact, of the many changes in gene regulation observed in the two, there were only 
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two genes that changed in both groups, i.e. HIRA (increased expression in both 
groups) and INPP4B (decreased expression in both groups).  
It is not unreasonable to conclude that despite their overt similarities, the two 
conceptualisations of meditation seem to be influencing the molecular biology of the 
practitioner quite differently. It suggests that relatively subtle differences in the way 
that a meditative method is defined and practiced can have implications that are 
significant not only in terms of semantics, philosophy and psychology but also 
biologically. In order to further explore the implications of the gene changes in both 
groups, I reviewed the available peer-reviewed literature that related to each of the 
gene changes that occurred in this study. The gene changes, although quite diverse, 
generally were for genes in three categories: (1) immune system/inflammation; (2) 
cancer; and (3) cell structure and function. This is described in further detail below. 
Overall, it appears that body scan meditation has altered the expression of a 
significantly larger number of genes when compared to mental silence meditation 
(body scan meditation influencing the expression of 3 times as many genes than 
mental silence meditation). Additionally, gene expression changes relating to 
immune function, cancer and cellular structure and function are apparent in both 
body scan and mental silence meditation groups. Interestingly, in my study no gene 
expression changes were observed relating to chronic inflammation despite the 
literature review identifying 6 studies which showed the contrary.  
My results (summarised in Table 5) thereby confirm the notion that the practice of 
meditation can induce gene expression changes specifically genes related to immune 
function, cancer and cellular structure and function. Previous RCTs by Manocha et 
al. showed that mental silence appears to have a specific effect on mood as well as 
some aspects of quality of life and an effect on the pathophysiology of asthma. 
Similarly, studies done by Rai et al. showed that mental silence was associated with 
improvements in quality of life, anxiety reduction, blood pressure control, beneficial 
electroencephalogram changes in epilepsy patients and decreased stress. The results 
of my study add to mental silence meditation research by providing a possible 
biological or molecular mechanism by which mental silence exerts its previously 
recorded clinical effects. For example, alterations in immune function gene 
expression may be a possible mechanism by which mental silence can exert an effect 
 55 
on asthma pathophysiology. It is difficult to draw definite conclusions but further and 
larger powered studies may be able to confirm these hypotheses.  
When compared to the literature review this tells me that the two meditation 
techniques that I studied have commonalities and differences. For some reason both 
types of meditation did not evoke gene expression changes relating to chronic 
inflammation. This could be due to the smaller participant size. From my literature 
review, it can be noted that the larger sample sized studies were able to detect 
changes in chronic inflammation gene expression. This could mean that these gene 
expression changes are so subtle that only larger powered studies are able to detect 
them. Additionally differences in fold change thresholds varied amongst the 6 studies 
which showed changes in chronic inflammatory gene expression, meaning that there 
was no standardised reference cut-off to be used. Specifically Creswell et al. (2012) 
used an FC cut off >= 1.25, D. S. Black et al. (2013) used an FC cut off of > 1.2.  
Putting methodological explanations aside, perhaps another reason might be these 
particular two techniques of meditation influence the body in ways that are different 
to the techniques studies in my literature review. Even though body scan meditation 
is categorised as a form of mindfulness, in reality it may be different altogether. 
Similarly, the mental silence meditation technique may be different to the other 
techniques. This once again highlights the importance of a consensus definition of 
meditation, without which it is difficult to draw conclusions on whether or not it 
exerts any non-specific effects.  
Immune function changes were substantial in both groups but they appeared to be 
potentially more beneficial in the mental silence group. A recently published review 
article concluded that there is some evidence that meditation has a beneficial impact 
on the immune system, however further studies are required to elucidate the 
mechanisms (D. S. Black & Slavich, 2016). The results of my study show additional 
evidence that meditation can have an impact on the immune system and provides a 
possible biological mechanism by which these immune system changes can occur 
that is, through epigenetic changes. Interestingly, there were differences between the 
groups with respect to the number of gene expression changes and the proportion of 
gene expression changes, which were deemed potentially beneficial. This leads me to 
believe that although both mental silence and body scan are considered types of 
 56 
meditation, they in fact may be impacting the body in different ways. To investigate 
this future larger power studies comparing two active types of meditation should be 
considered.  
Numerous studies demonstrate meditation as an effective tool for improving negative 
psychological and physical experiences relating to cancer patients. However, up until 
now there have been no studies and therefore no evidence that meditation can 
directly alter biological processes relating to cancer. My study shows, both mental 
silence and body scan meditations appear to have elicited cancer related gene 
expression changes. This in turn may lead to altered levels of translated proteins that 
then act to alter cancer pathways or processes with the possibility of ultimately 
altering the pathophysiology of cancer. No studies in the literature review identified 
cancer related gene expression changes. This could be due to a couple of reasons. 
Firstly, most cancer genes have a significant overlap with other gene categories. For 
example, a cancer gene may also be known to play a role in chronic inflammation, 
immune function and other cellular processes. Therefore, it is possible that previous 
studies have categorised cancer genes differently, that is, by allocating cancer genes 
to other categories. Secondly, none of the studies in the literature review studied the 
effects of mental silence and body scan meditations specifically. Therefore it may be 
possible that observed cancer gene expression changes are only associated with these 
two specific definitions of meditation.  
As established previously, gene expression changes relating to cellular structure and 
function were present in 50% of the studies identified in the literature review. Both 
mental silence and body scan meditation showed significant changes in this category. 
Interestingly, this category had the largest number of gene expression changes (34 
gene changes across both groups as compared to 8 immune related genes and 10 
cancer related genes). This suggests that alterations in cell structure and function 
related genes may be another biological mechanism through which meditation exerts 
its purported effects.  
As discussed previously, research over the past 10 years has focused around a 
cellular enzyme known as telomerase. In my study, I found that hTERT was 
significantly down regulated in the body scan meditation group (FC = −1.32). On the 
other hand the mental silence group appeared to have no effect on this gene‟s 
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expression. The down regulation of hTERT is contradictory to previous results, 
which showed that meditation increased the activity of telomerase related genes. This 
may be attributed to the relatively lower sample size of the study not being able to 
detect subtle changes associated with telomerase activity. On the other hand there 
may be different underlying mechanisms of body scan meditation which may lead to 
a reduction in hTERT expression. To further investigate the full effect of body scan 
meditation a larger powered study using qPCR (quantitative polymerase chain 
reaction) experiments to validate the results should be considered. Although these 
changes were observed in the body scan meditation group, it is important to note that 
hTERT is only one of many subunits which comprise the telomerase enzyme. Thus, 
we may not fully understand the functional impact the down regulation of hTERT 
may have on telomerase (although logically it should decrease its function).  
Mental silence meditation appeared to have no effect on hTERT, possibly because of 
a small sample size leading to a type 1 error. However, mental silence increased the 
expression of TNKS2 which has been shown to interact with telomerase. 
Interestingly, studies have shown TNKS2 is involved in telomere maintenance or 
elongation and also essential for normal growth and development in mice (Chiang et 
al., 2008; Hsiao, Poitras, Cook, Liu, & Smith, 2006). Overall, my results demonstrate 
that meditation can alter the expression of telomerase related genes; however, the 
biological impacts of these alterations are difficult to ascertain.  
Both meditation groups also invoked gene expression changes relating to a myriad of 
other cell functions and to cell structure. Overall, these gene expression changes 
were seen as potentially more beneficial to the mental silence practitioner, however it 
may be difficult to conclude the exact overall biological impact it may have on the 
practitioner. 
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Table 4: Gene changes categorised by: total, immune system related, cell 
structure and function, cancer genes 
 Number of Genes Changed 
  With Potential Impact Function 
Treatment Total 
Beneficial Detrimental 
Understood 
but 
indeterminate 
impact 
Not 
understood 
(but genes 
changed) 
Total Genes      
Mental 
Silence 16 9 0 5 2 
Body Scan 48 5 10 23 10 
Immune 
Function     
 Mental 
Silence 4 3 0 1 – 
Body Scan 4 1 3 0 – 
Cell 
Structure & 
Function     
 Mental 
Silence 6 4 0 2 - 
Body Scan 28 3 4 21 – 
Cancer 
Related     
 Mental 
Silence 4 2 0 2 – 
Body Scan 6 1 3 2 – 
 
In order to explore the function of each of the genes implicated in my study, I carried 
out a function search using the Biotechnology Information, US National Library of 
Medicine‟s gene database (http://www.ncbi.nlm.nih.gov/gene) and through the 
UniProtKB (http://www.uniprot.org/uniprot/). It is important to point out that the 
results from this gene expression study may not directly reflect the activity of the 
gene products, due to the numerous complex pathways that exist in the human 
biological system. This means that we can only speculate that these gene expression 
changes are categorised as being beneficial or detrimental. Although, it is possible to 
analyse the expression of gene products with new emerging technologies such as 
protein array chips, the cost of doing so is significantly larger than gene array 
analysis.  
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Gene changes associated with mental silence 
Overall, of the 16 genes changed in the meditation group, 4 are related to immune 
system functions and 6 are involved in cell structure and function, 4 involved in 
cancer processes (see Table 2). The remaining 2 genes did not fit in any of these 
categories.  
Within these 4 immune related function genes the literature suggests that 3 of the 
gene changes are potentially beneficial and one of them could have an undetermined 
effect on the practitioner. With regard to the 6 cell structure and function related 
genes the literature suggests that 4 of these gene changes are beneficial for 
practitioners and 2 have their functions understood but their impacts on the 
practitioner are unknown. Of the 4 cancer related gene changes, 2 were found to be 
potentially beneficial and 2 genes had their functions not understood yet.  
Immune related genes 
Potentially beneficial 
• CD84 (CD84 molecule) −1.6 FC 
• CLEC10A (C-type lectin domain family 10, member A) −1.6 FC 
• IGHG3 (immunoglobulin heavy constant gamma 3) 3.03 FC 
Impact unknown 
• NOTCH2NL (notch 2 N-terminal like) −1.92 FC 
Cancer related genes 
Potentially beneficial 
• TBL1X (transducin (beta)-like 1X-linked) −1.86 FC 
• SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator 
of chromatin, subfamily A, member 2) −1.57 FC 
Impact unknown 
• KIAA0101 2.01 FC 
• PXLNC1 (Plexin C1) −1.59 FC 
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Cell structure related genes 
Potentially beneficial 
• TNKS2 (tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 
2) 1.52 FC 
• LMAN1 (lectin, mannose-binding, member 1) 1.8 FC 
• HIRA (histone cell cycle regulator) 1.8 FC 
• INPP4B (inositol polyphosphate-4-phosphatase, type II) −1.71 FC 
Impact unknown 
• WDFY1 (WD repeat and FYVE domain containing, member1) −1.5 FC 
• OSBPL8 (oxysterol binding protein-like, member 8) −1.68 FC 
Genes with poorly understood function  
• PNISR (PNN-interacting serine/arginine-rich protein) −1.66 FC 
• MBNL1 (muscleblind- like splicing regulator 1) −1.52 FC 
Gene changes observed only in the body scan group 
Overall, of the 48 genes changed in the control group, 4 are related to immune 
system functions and 28 are involved in cell structure and function, 6 genes are 
involved in cancer processes and 10 of the genes currently have no known function 
(see Table 3).  
Within the 4 immune related function genes the literature suggests that only 1 gene 
change is potentially beneficial, while the other 3 genes are potentially detrimental to 
the practitioner. With regard to the 28 cell structure and function related genes the 
literature suggests that 3 of these gene changes are beneficial for practitioners, while 
4 may be detrimental for practitioners and the function for 21 of these genes are 
unknown. Within the cancer related genes 3 of the gene changes have been shown to 
have a potentially detrimental impact on the practitioner while only one was shown 
to have a potential beneficial impact and 2 gene changes with an unknown impact on 
the practitioner.  
Immune related genes 
Potentially beneficial 
• PRKD3 (protein kinase D3) −1.92 FC 
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Potentially detrimental 
• PTPRC (protein tyrosine phosphatase, receptor type C) −2.59 FC 
• KCNA3 (potassium voltage-gated channel, shaker-related subfamily, member 
3) −1.78 FC 
• ITCH (itchy E3 ubiquitin protein ligase) −1.68 FC 
Cell structure related genes 
Potentially beneficial 
• TRIB2 (tribbles pseudokinase 2) −1.51 FC 
• HIRA (histone cell cycle regulator) 1.55 FC 
• INPP4B (inositol polyphosphate-4-phosphatase, type II) −2.32 FC 
Potentially detrimental 
• PARP14 (poly (ADP-ribose) polymerase family, member 14) −0.71 LOGFC 
• DYNC1H1 (dynein, cytoplasmic 1, heavy chain 1) −1.63 FC 
• RNGTT (RNA guanylyltransferase and 5'-phosphatase) −1.55 FC 
• CD3G (CD3g molecule, gamma (CD3-TCR complex)) −1.54 FC 
Impact unknown 
• ARHGEF3 (rho guanine nucleotide exchange factor (GEF) 3) −1.74 FC 
• PCDH9 (protocadherin 9) −1.67 FC 
• UBXN4 (UBX domain protein 4) −2.09 FC 
• TAF15 (TAF15 RNA polymerase II, TATA box binding protein (TBP)-
associated factor) −1.57 FC 
• P2RY13 (purinergic receptor P2Y, G-protein coupled, 13) −1.73 FC 
• BRWD1 (bromodomain and WD repeat domain containing 1) −1.65 FC 
• ZNF644 (zinc finger protein 644) −1.63 FC 
• TTC3 (tetratricopeptide repeat domain 3) −1.61 FC 
• GNPNAT1 (glucosamine-phosphate N-acetyltransferase 1 −1.58 FC 
• USP34 (ubiquitin specific peptidase 34) −0.65 LOGFC 
• CAMSAP1 (calmodulin regulated spectrin-associated protein 1) −1.57 FC 
• CLK4 (CDC-like kinase 4) −1.54 FC 
• AKAP11 (A kinase (PRKA) anchor protein 11) −1.54 FC 
• CHD4 (chromodomain helicase DNA binding protein 4) −1.52 FC 
• ETF1 (eukaryotic translation termination factor 1) −1.52 FC 
• CLSTN1 (calsyntenin 1) −1.52 FC 
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• PARN (poly(A)-specific ribonuclease) −1.50 FC 
• MAN1A1 (mannosidase, alpha, class 1A, member 1) −1.55 FC 
• ETS1 (V-ets avian erythroblastosis virus E26 oncogene homolog 1) −1.57 FC 
• ITGA4 (integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 
receptor)) −1.53 FC 
• RAB2B (member RAS oncogene family) 1.61 FC 
Cancer genes 
Potentially beneficial 
• EZR (ezrin) −1.83 FC 
Potentially detrimental 
• UFL1 (UFM1-specific ligase 1) −1.90 FC 
• RAD23B (RAD23 homolog B) −1.70 FC 
• BCLAF1 (BCL2-associated transcription factor 1) −1.68 FC 
Impact unknown 
• ZKSCAN1 (zinc finger with KRAB and SCAN domains 1) −1.60 FC 
• CD44 (CD44 molecule) −1.88 FC 
Genes with poorly understood function 
• CTDSPL2 (CTD (carboxy-terminal domain, RNA polymerase II, polypeptide 
A) small phosphatase like 2) −1.71 FC 
• TMEM106B (transmembrane protein 106B) −1.71 FC 
• TMEM260 (transmembrane protein 260) −2.19 FC 
• TRIM49D2 (TRIM49D2 tripartite motif containing 49D2) 1.81 FC 
• KLHL18 (kelch-like family member 18) 1.51 FC 
• RNF145 (ring finger protein 145) −1.50 FC 
• SLC25A36 (solute carrier family 25 - pyrimidine nucleotide carrier, member 
36) −1.54 FC 
• ZSWIM6 (zinc finger, SWIM-type containing 6) −1.57 FC 
• ZNF800 (zinc finger protein 800) −1.57 FC 
• RIOK1 (RIO kinase 1) −1.51 FC 
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Theory, literature review and current study: gene 
expression changes 
In my introduction I have described the most popular and current theories regarding 
meditation‟s potential biological mechanisms of action and the evidence for each. In 
summary, they can be categorised as follows: 
• the modulation of the stress and chronic inflammatory pathways (NF-κB) 
• expression changes of immune function genes 
• expression changes of cancer related genes 
• more recently, expression changes of certain cellular structure and function 
genes leading to increased longevity. 
For ease of discussion, the gene expression changes found in my study have been 
sorted into the same categories described above. However, in reality there is a certain 
degree of overlap between these categories. For example, CD84 is a gene which 
codes for a protein expressed by B lymphocytes and macrophages. A number of 
functional studies has confirmed this. Thus it would seem logical that CD84 would 
be positioned in the immune function category. However, the literature also shows 
that CD84 is implicated in Kawasaki disease which is characterised by inflammation 
of blood vessels throughout the body. So, it can also be argued that CD84 might be 
equally well positioned in the chronic inflammation category. For the purposes of 
this thesis, I chose to put CD84 in the immune function category because the 
majority of studies and gene banks have categorised CD84 as an immune gene. 
Similarly, wherever a gene might belong to more than one category I allocated it 
based on what the majority of the literature or gene banks categorised it as.  
Chronic inflammation 
As discussed previously chronic inflammation is implicated in the causation in a 
number of significant NCDs. Hence strategies to reduce chronic inflammation levels 
are regarded as key to reducing the risk of developing these NCDs at an individual 
and population level. Lifestyle strategies, such as the reduction of saturated fats in 
the diet, for example, are thought to exert much of their benefit by reducing chronic 
inflammation. Current understandings of chronic inflammation are increasingly also 
implicated in psychological stress and mental illnesses (such as depression and 
Alzheimer‟s disease).  
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My literature review identified 10 studies that investigated meditations impact on 
gene expression. Interestingly 6 of the studies involved gene expression changes 
relating to chronic inflammation. Antoni et al. (2012), D.S. Black et al. (2013) and 
Creswell et al. (2012) all showed a reduction in NF-κB response elements. Bhasin et 
al. (2013), Dusek et al. (2008) and Kaliman et al. (2014) were the other 3 studies and 
showed a significant down regulation of chronic inflammatory genes.  
In my study, contrary to what was expected, neither the mental silence group nor the 
body scan meditation group showed any alterations in inflammatory gene expression. 
Possible reasons for the absence of change in this category are discussed later in this 
section.  
Immune function 
In my study, both the mental silence and body scan meditations elicited gene 
expression changes under the immune function category. The mental silence group 
altered 4 genes of which 3 were down regulated (NOTCH2NL, CLEC10A, CD84) 
and 1 up regulated (IGHG3). IGHG3 had the largest fold change out of all the gene 
changes in the mental silence group with a FC of 2.0. It codes for an immunoglobulin 
protein, which is a key component of antibodies. Therefore, an increased expression 
of this gene may lead to a larger number of antibody sub-units being produced and 
hence a more efficient immune system. Black et al. presented similar up regulation of 
immunoglobulin related transcripts such as IGJ (FC 1.4) and IGLL3 (FC 1.2) but not 
IGHG3 (D. S. Black et al., 2013). The literature surrounding the function of some of 
these genes leads to the following possibilities: 
• The down regulation of CLEC10A and CD84 may be beneficial to the 
practitioner. 
• The down regulation of NOTCH2NL has an unknown impact as the function 
of this gene is not yet fully understood. 
The body scan meditation elicited a down regulation of 4 genes: PRKD3, PTPRC, 
KCNA3 and ITCH. The literature reveals the following in regards to these gene 
expression changes: 
• PRKD3 is thought to be involved in the regulation of immune functions 
through intracellular signalling. The down regulation of PRKD3 was 
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identified as being potentially beneficial as the expression of this gene has 
been shown to contribute to the proliferation of cancerous cells in the 
prostate.  
• PRPRC was identified as being involved in T and B cell antigen receptor 
signalling and as a tumour suppressor gene. Thus, a decrease in gene 
expression may possibly have a detrimental impact on the immune system‟s 
function and protection against cancer. 
• KCNA3 was identified as playing a role in T lymphocyte differentiation and 
activation. Hence a reduction in this gene‟s expression may negatively impact 
the adaptive immune response.  
• ITCH codes of an enzyme that targets specific proteins for lysosomal 
degradation. It is also involved in the control of T lymphocyte differentiation 
and activation. Therefore, a down regulation of this gene may negatively 
affect the ability for T lymphocytes to perform at their maximum capabilities.  
Overall, both mental silence and body scan meditations appear to alter immune 
related gene expression. The gene expression changes altered after mental silence 
and body scan meditations are primarily involved with adaptive immune function (T 
lymphocytes). On the other hand, genes differentially expressed in Antoni et al‟s 
study were primarily involved with innate immune function (anti-viral proteins) 
(Antoni et al., 2012).  
Although both the mental silence and body scan meditations altered the expression of 
adaptive immune function genes, they appeared to have altered the expression of 
genes uniquely such that: 
• The mental silence group appears to have a beneficial impact on the immune 
system. 
• The body scan group appears to have a negative impact on immune function.  
These results are a step forward in understanding how meditation, specifically the 
technique of mental silence, is able to alter immune function. Although, the impacts 
of these gene expression changes are theoretical, further robust studies are warranted.  
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Cancer 
Cancer, as discussed previously, can be associated with many modern lifestyle risk 
factors. Lifestyle modifications that can alter these risk factors may ultimately reduce 
the risk of getting cancer. Although there is a body of evidence indicating that 
meditation is useful in improving cancer related cognitive dysfunction, there is little 
evidence that meditation can alter biological processes directly related to cancer 
(Ando et al., 2009; Biegler, Chaoul, & Cohen, 2009; Y. H. Kim, Kim, Ahn, Seo, & 
Kim, 2013).  
The results from my study are the first indications that meditation can influence 
cancer related gene expression. Mental silence altered the expression of 4 cancer 
related genes of which 1 was up regulated and 3 down regulated. Of the 4 cancer 
gene expression changes, 2 of the changes were deemed beneficial while the other 2 
changes were deemed as having an unknown impact on the body.  
Mental silence 
TBL1X had a decreased level of expression and as its role as a possible oncogene 
was identified in 2014, it can be proposed a decrease in TBL1X‟s expression may 
have a beneficial impact on the practitioner (J. Y. Li, Daniels, Wang, & Zhang, 
2015). The next gene, SMARCA2, was shown to be involved in 20% of all cancer 
types and it is proposed that inhibitors of SMARCA2 may have a therapeutic role in 
treating cancers, which have loss of function mutations in its related gene 
(SMARCA4) (Hoffman et al., 2014). Thus it may be possible that a down regulation 
of SMARCA2 as observed in our study may provide a therapeutic benefit for cancers 
harbouring a loss of function mutation in SMARCA4.  
KIAA0101 was the only up-regulated gene in the cancer category. Numerous studies 
have implicated KIAA0101 gene overexpression in a number of cancers such as 
pituitary tumours, hepatocellular carcinoma, gastric cancer, oesophageal cancer and 
adrenal cancer (Cheng et al., 2013; Jain, Zhang, Patterson, & Kebebew, 2011; Liu et 
al., 2012; Roche et al., 2015; Zhu et al., 2013). However, a study in 2009 identified 
its role as a regulator of DNA repair during DNA replication (Turchi et al., 2009). 
The differing biological roles of KIAA0101 make it hard to determine whether an 
increase in this genes expression will be beneficial or detrimental. Similarly, 
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conflicting studies make it hard to determine the effect of expression changes for the 
PLXNC1 gene. Whether a decrease in this genes expression is beneficial or 
detrimental is not fully known. PLXNC1 codes for plexin C1 that is a protein 
involved in inflammation and cancer cell proliferation. PLXNC1 has been shown to 
play a role in delaying the progression of melanoma. Chen et al. demonstrated that a 
loss of function of PLXNC1 increased the migration and proliferation rate of 
melanoma cells (Chen, Soong, Mohanty, Xu, & Scott, 2013). Our study shows a FC 
of −1.60 potentially making this a beneficial change for practitioners.  
Body scan meditation 
On the other hand, body scan meditation altered the expression of 6 cancer related 
genes, all of which were down regulated. There was only one gene change which 
was identified as having a potentially beneficial impact. EZR a gene coding for a 
protein which serves as a potential biomarker for hepatocellular carcinoma was down 
regulated, hence providing a potentially beneficial impact on the practitioner (Flores-
Tellez, Lopez, Vasquez Garzon, & Villa-Trevino, 2015).  
The down regulation of 3 of the genes regulated by body scan meditation in this 
category were deemed to have a possible detrimental impact on the practitioner. The 
first gene UFL1 is known to be a negative regulator of the NF-κB pathway, a novel 
regulator of C53 tumour suppressor gene and also implicated in breast cancer 
initiation (Wu, Lei, Mei, Tang, & Li, 2010; Yoo et al., 2014). Therefore, the 
decreased expression of this gene may promote chronic inflammation via the NF-κB 
pathway and alter cancer processes. The second gene, RAD23B, has been identified 
as a tumour suppressor gene which is also involved in nucleotide excision repair 
(Linge et al., 2014; Schärer, 2013). The third gene, BCLAF1, has been shown to act 
as a tumour suppressor and is also known to be involved in the regulation of DNA 
damage and repair genes (Lee, Yu, Gunawardena, Xie, & Chen, 2012; Savage et al., 
2014). It can be thus argued that the down regulation of both RAD23B and BCLAF1 
may have a detrimental impact on the practitioner.  
Gene expression changes of 2 genes had unknown impacts. These included CD44 
and ZKSCAN1. The literature surrounding CD44 is divided, with studies 
demonstrating its cancer initiating properties while others demonstrating its cancer 
supressing properties. A 2011 review describes CD44 as having different roles 
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during different stages of cancer, hence a decrease in CD44 expression as seen in the 
control group may have various unknown impacts on cancer processes (Louderbough 
& Schroeder, 2011). Similarly, there is not enough evidence to suggest any beneficial 
or detrimental impacts for ZKSCAN1.  
The observed cancer gene expression changes invoked by mental silence and body 
scan meditations give the first indications that meditation may act on cancer 
pathways in the body. However, it must be noted that genes involved in cancer 
processes are also implicated in normal cell functioning. Thus, the degree of overlap 
between cancer and other gene categories is enormous. Keeping this in mind, I have 
done my best to include genes in the category of cancer based on the number of 
studies implicating them in cancer. In instances where there are more studies 
implicating them in normal cellular processes, I have included them in other 
categories.  
Cell structure and function 
As mentioned previously the healthy functioning of our cells creates an opportunity 
for physiological homeostasis and longevity. There are a number of cellular 
components, which all contribute uniquely through a complex network of 
intracellular signalling to achieve homeostasis.  
Of the 10 studies included in my literature review, 5 showed that meditation can alter 
the genes which code for a number of these cellular components. A summary is as 
follows: 
• In 2005, Falun Gong practitioners were found to have: 
○ down regulation of ubiquitin related proteins (E1, E2, E3), ribosomal 
proteins, DNA repair (RAD52, ERCC), apoptotic genes (BLC2, BCL-xl) 
○ up regulation of heat shock proteins (HSP70, HSP40-3). 
• In 2008, Sudarshan Kriya practitioners were found to have up regulation of 
glutathione S transferase (GST-P1) and PTGS2. HTERT and BCL2 were 
increased but were not significant. 
• In 2012 Ravnik-Glavac et al. showed that switching to a higher state of 
consciousness could alter the expression of thousands of genes of which a 
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large proportion were related to cell structure and function (using a cut-off 
> 1.3 FC). 
• In 2013 Sudarshan Kriya and related practices were shown to down regulate 
the expression of AVIL (a gene coding for a structural protein) and NFE2 (a 
gene coding for a master regulator of megakaryocyte differentiation and 
platelet production). 
• In 2014, mindfulness meditation practitioners were found to have a decreased 
expression of histone deacetylases, specifically HDAC2, HDAC3, HDAC9 
and histone modifiers (H4ac and H3K3me3). 
My study provides additional evidence that meditation, specifically mental silence 
and body scan meditations, can elicit gene expression changes related to cell 
structure and function. The mental silence group altered 4 genes of which 2 were up 
regulated and 2 down regulated. The body scan meditation altered 26 genes of which 
only one was up regulated and the remaining 25 down regulated.  
Potentially beneficial gene expression changes – mental silence 
The mental silence group was shown to up regulate TNKS2 which has been 
implicated in negatively regulating telomerase through the release of endogenous 
TRF1 (Hsiao et al., 2006). As a deregulation of telomerase can result in a cell turning 
cancerous/immortal, it can be proposed an up regulation of TNKS2 as seen in mental 
silence practitioners may have cancer-protecting effects through its actions on TRF1.  
Another gene‟s expression affected by mental silence meditation was LMAN. This 
codes for a membrane anchor protein that recognises sugar residues of glycoproteins, 
glycolipids, or glycosylphosphatidyl inositol anchors. It functions to sort and recycle 
proteins and lipids (Duellman, Burnett, Shin, & Yang, 2015; Zheng & Zhang, 2013). 
Its increased expression elicited by mental silence meditation may therefore 
beneficially affect the cells sorting and recycling processes.  
Unknown impact of gene expression change – mental silence 
Mental silence meditation also decreased the expression 2 genes WDFY1 and 
OSBPL8, both of which have limited literature surrounding their function making it 
hard to say if a decreased expression would have a beneficial or detrimental impact 
on the body.  
 70 
Potentially beneficial gene expression changes – body scan 
meditation 
Body scan meditation only had one potentially beneficial gene expression relating to 
cell structure and function. The down regulation of TRIB2, a protein kinase with 
oncogenic properties, may prove to be beneficial to practitioners (Hill et al., 2015).  
Potentially detrimental gene expression changes – body scan 
meditation 
Of the 26 gene expression changes 3 were identified as being potentially detrimental. 
The first gene which was negatively expressed was PARP14. In 2015, it was found 
to be a novel factor in alleviating replication stress and enhancing genomic stability 
(Krishnamurthy et al., 2014). It may be possible that the decrease in expression of 
this gene may negatively effect the stability of cells during replication, and hence 
increase the rate of cell death.  
Another gene found to have decreased expression was DYNC1H1. This gene codes 
for an ATP powered protein (also known as a motor protein) which is involved in a 
large number of cellular processes such as the transport of organelles and the 
functioning of the mitotic spindle during the cell division phase (Ayloo et al., 2014). 
Mutations in this gene lead to phenotypes such as Charcot-Marie-Tooth disease and 
mental retardation (Ding et al., 2016; Weedon et al., 2011). Due to its crucial role in 
cellular function, we propose that a decrease in this gene‟s expression may have a 
detrimental impact.  
The body scan meditation group also down regulated a RNGTT which functions as 
an mRNA and RNA capping enzyme. Capping is essential for mRNA/RNA stability, 
export and translation (Mukherjee, Bakthavachalu, & Schoenberg, 2014; Pillutla, 
Shimamoto, Furuichi, & Shatkin, 1998). A decreased expression of RNGTT may 
possibly reduce the capping and thus cause a loss of efficiency of mRNA/RNA.  
Another gene, CD3G, is a protein that forms part of the CD3 T cell receptor complex 
and is involved in antigen recognition. Defects in this gene have been linked to T cell 
immunodeficiency and thus a decreased expression of CD3G may have a negative 
effect on T cell function (Fischer, de Saint Basile, & Le Deist, 2005; Gokturk et al., 
2014).  
 71 
Unknown impact gene expression changes – body scan 
meditation 
Although the body scan meditation elicited one potentially beneficial and 3 
potentially detrimental gene expression changes the majority of the 26 gene 
expression changes were classified as having an unknown effect on the body. This 
was mainly due to the lack of functional studies present in the literature. Within the 
category of cellular structure and function, these gene changes could be classified 
further as the following (National Center for Biotechnology Information, 2005): 
Protein binding 
• ARHGEF3 
• UBXN4 
• TAF15 
• BRWD1 
• TTC3 
• GNPNAT1 
• USP34 
• CLK4 
• CHD4 
• CLSTN1 
• RAB2B 
DNA binding 
• ZNF644 
• ETS1 
Cell adhesion  
• PCDH9 
• ITGA4 
Signal transduction 
• P2ry13 
Microtubule/calmodulin/spectrin binding (cytoskeletal organisation) 
• CAMSAP1 
Protein kinase A binding 
• AKAP11 
RNA binding 
• ETF1 
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Nucleotide binding 
• PARN 
Mannosidase activity 
• MAN1A1 
Other gene expression changes worth noting (< 1.4 FC) 
Meditation has been shown to significantly alter the activity of telomerase, which has 
been implicated in cell longevity (Schutte & Malouff, 2014). Interestingly the body 
scan meditation group elicited a significant down regulation of hTERT by FC −0.11, 
while there was no change in the mental silence group.  
Another gene, GSTZ1 (glutathione S-transferase zeta 1) is part of the glutathione S 
transferase superfamily of genes which all encode for enzymes which play a 
significant role in detoxification of carcinogens and mutagens (Strange, Spiteri, 
Ramachandran, & Fryer, 2001). Interestingly, the body scan group displayed a 
significant (p < 0.05) down regulation of this gene by −0.11 fold while the mental 
silence group had no effect.  
Cell structure and function genes in relation to previous studies 
Meditation group 
There were a number of genes which were altered in both our study and in previous 
studies. OSBPL8 was found to be altered in the mental silence group with a fold 
change of FC = −1.68. This is the opposite direction of change reported in a study by 
Antoni et al. (where it was up regulated instead of down regulated) (Antoni et al., 
2012).  
TNKS2 was a gene which was down regulated in the meditation group (FC = 1.52). 
In Ravnik-Glavac et al‟s study it was also seen to be down regulated after the 
meditator had switched to a higher state of consciousness (Ravnik-Glavac et al., 
2012).  
Body scan group 
In the body scan group, TRIB2 (FC = −1.51) had the same direction of change as 
Ravnik-Glavac et al‟s study (Ravnik-Glavac et al., 2012). Another gene CHD4 (FC = 
−1.52) was found to be down regulated in the body scan group which parallels 
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Creswell et al‟s study (logFC = −0.32) (Creswell et al., 2012). ZNF644 was found to 
be down regulated in the body scan group (FC = −1.63) and also down regulated in 
Antoni et al‟s study where CBSM was the intervention. PARP14 a gene involved in 
regulating transcription was found to be down regulated in our control group and 
Antoni et al‟s study (FC = −1.63) (Antoni et al., 2012). RAD23B was down 
regulated in the control group by FC = −1.70 and in Creswell et al‟s study it was 
shown to be up regulated. CTDSPL2 was down regulated (FC = −1.71) by both our 
control group and the intervention group in Antoni et al‟s study.  
Categories shown to be unaffected by our study 
Our study along with 7 other studies did not display any changes in ribosomal genes. 
These were only demonstrated to be differentially expressed in Li‟s 2015 pilot study 
of Qigong practitioners, Ravnik-Glavac et al‟s 2012 study and Dusek et al‟s 2008 
study (Dusek et al., 2008; Q. Z. Li et al., 2005; Ravnik-Glavac et al., 2012).  
It is apparent that meditation, specifically mental silence and body scan meditation 
can invoke gene expression changes in a large number of cellular structure and 
function genes. This confirms the results of 5 previous studies which investigated the 
gene expression changes associated with a variety of meditations.  
Strengths and weaknesses of my study 
My study has a number of strengths that make it a powerful stepping stone in 
meditation epigenetic research. It utilised a randomised controlled trial study design 
making it the fourth RCT exploring gene expression changes associated with 
meditation. The strengths associated with the study design included: 
• The participants, the head researcher and the data entry personnel were all 
blinded to the allocation of participants. 
• The participants were blinded to the hypothesis of the study. 
Additionally, it was the first gene expression study comparing two different 
definitions of meditation namely body scan and mental silence meditations. This also 
adds a new perspective to the growing body of meditation research that different 
definitions of meditation may have different biological impacts on the body.  
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Limitations of this study included the sample size of 48 participants, after taking 
dropouts into consideration. As a result of having only 24 participants in each 
intervention group, type 1 errors may have occurred especially when trying to detect 
possibly subtle genetic changes associated with meditation. Future studies should 
aim to include at least double this, that is 50 participants per intervention group to 
increase the statistical strength of the study. Additionally, participants could be asked 
to increase their face-to-face participation hours from 1 hour weekly to 1 hour every 
day. Similarly, the total intervention time of 5 weeks could be extended to possibly 
double that. Limitations surrounding the method of advertisement for the study 
meant that only participants from the University of Sydney would respond. Overall, 
this could have an impact on the external validity of the clinical trial and future 
studies should aim to recruit participants from all aspects of society.  
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Conclusion and implications for the future 
My literature review found that there are 10 studies in the literature looking at the 
genetic impacts of meditation. Of those 10 studies, none looked at mental silence 
orientated forms of meditation and none compared two different definitions of 
meditation, despite the fact that there are many varying definitions of meditation in 
the literature. In addition, despite 40 years of research the scientific community is yet 
to come to a consensus definition of what meditation is or what it might be defined 
as. Even more importantly, there is no conclusive evidence of a specific effect with 
regards to meditation as a generic category. Having said this there is a technique of 
meditation called Sahaja yoga for which there is a small but emerging body of 
evidence for a specific effect, particularly in association with the mental silence 
experience associated with that technique of meditation.  
In order to ascertain firstly, the mechanisms by which Sahaja yoga may exert its 
biological effects, secondly by which meditation might exert its biological effects 
and thirdly whether or not there might be differences between meditation techniques 
I conducted a randomised controlled trial involving 50 subjects where I compared 
Sahaja yoga meditation to body scan meditation assessing gene expression changes 
before and after. As a result of this study the between groups analysis found only one 
significant difference, however there were substantial between group differences that 
were qualitatively different between the two groups. These differences appear to 
indicate that the lack of between group of differences is most likely to be due to type 
1 error. The within group changes nevertheless point towards the idea that the two 
techniques of meditation have very different biological impacts. The main effects 
being on immune regulation, cell structure and function, and cancer risk. 
The outcomes of my study provide preliminary evidence that appears to show that 
different mediation techniques have different biological impacts on the body. This is 
based on the fact that gene expression changes were found to be unique when 
comparing the mental silence and body scan meditation groups. It is not 
unreasonable to consider the possibility that the alteration of gene expression 
changes in the categories of cancer, inflammation and cell structure and function may 
lead to different biological outcomes. This might therefore bring about different 
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biological outcomes in different practitioners of meditation. While purely 
speculative, it appears that the gene changes in the mental silence group may be more 
associated with favourable health effects as compared to the changes that were 
observed in the body scan meditation group. However, I recognise that this 
observation is speculative but nevertheless the implications are fascinating and 
warrants further research.  
In conclusion, this study clearly suggests that techniques of meditation with different 
definitions, may well have different epigenetic implications and this supports the 
idea that was discussed earlier in my thesis that grouping all forms of meditation 
under a single rubric is an inadequate way of understanding the effects of meditation. 
Different approaches to meditation, because they have different biological 
implications, ought to be clearly distinguished from each other and studied 
separately. This is supported not only by the gene expression changes that were 
unique to each group in my study, but also the fact that some of these gene 
expression changes were unique when compared to previous studies.  
Additionally, this study also supports the idea that the different definitions of 
meditation are important to understand and that there may be only some definitions, 
that while meditation as a generic category may not be associated with specific 
effect, there may be some definitions that are. The mental silence definition of 
meditation is one of those categories for which I have already discussed the evidence 
suggesting that it is a worthwhile definition to assess. In order to further explore 
these important findings, I suggest that the following should be done.  
My study should be replicated on a larger scale in order to highlight any subtle 
between group differences concerning gene expression changes for both mental 
silence and body scan meditation. Sample sizes with 50 participants or greater in 
each meditation group would be appropriate. Additionally, future studies would 
ideally be conducted with greater levels of methodological rigor. This may involve 
extending the intervention time, increasing the amount of time each participant 
spends meditating per week and also the confirmation of any significant gene 
expression changes through quantitative PCR determinations. Although costly, these 
additional measures would not only allow us to detect subtle gene expression 
changes that seem to be associated with meditation, but also provide a valid means of 
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confirming whether or not there is a biological (measured through gene expression 
changes) difference between two definitions of meditation.  
In addition, other definitions of meditation should be assessed in a similar way; i.e. 
randomised controlled trials which compare different definitions of meditation would 
allow us to confirm the preliminary idea that different definitions of meditation have 
different genetic impacts on the body. Future comparison studies may also shed light 
on the possibility that due to the different definitions of meditation having different 
biological impacts on the body, it is plausible that some of these definitions may be 
potentially more beneficial than others. On the other hand it may also be the case that 
some definitions of meditation may be detrimental to practitioners.  
In order to enhance the validity of future studies it is important to establish a 
connection between meditation invoked gene expression changes and how these 
relate to physical and mental health outcomes in the practitioner. Physical and mental 
health outcomes could include mood, quality of life and mortality (for possible long-
term cohort studies). Until now, there has been no attempt to correlate physical and 
mental health outcomes with gene expression changes due to meditation. 
Discovering the relationship between these two parameters will help us better 
understand what benefits are achieved through the alteration of specific genes. 
Therefore giving us additional insight on the biological mechanism of action through 
which meditation acts.  
With regards to the mental silence definition of meditation (Sahaja yoga), epigenetic 
changes should be correlated with the degree to which practitioners are experiencing 
mental silence. These can then be further correlated to physical and mental health 
outcomes described previously. This would allow us to determine whether or not 
there is a connection between mental silence and enhanced physical and mental 
health.  
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Appendix 1 – Body Scan Meditation 
Sessions were held every Sunday for 1 hour. For the first session participants from 
both groups were asked to arrive at 3:00pm. A briefing was given and participants 
asked to fill out consent pre-questionnaires. This was followed by blood collection 
performed by qualified nurses. Participants were then divided into their randomly 
allocated groups and told to attend different venues.  
At 4:00pm a guided meditation session was led by an instructor. Participants were 
told to sit or lie down in a comfortable position and then told to follow a 19 minute 
guided body scan meditation audio track which was played through a sound system. 
Following this participants were allowed to socialise and food was provided. 
Participants were also given a copy of “The relaxation and stress reduction 
workbook” which they were told to read at some stage throughout the study period. 
A copy of that book: 
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Participants were also given an audio CD of the guided meditation and were advised 
to listen to this every day during their meditation. The transcript of the guided body 
scan meditation is as follows (available for download from: 
http://www.uvm.edu/~CHWB/psych/?Page=exercises.html&SM=mindfulnessmenu.
html): 
“This is the body awareness exercise.  For this exercise find a position.  Either seated 
comfortably with your neck supported or lying down.  You may wish to loosen any 
belts.  Take off your glasses.  And just check in and make sure that your body is 
comfortable.  As we go through this exercise keep in mind an attitude of accepting 
whatever happens.  Non-striving and in other words not trying to make anything 
happen.  But just being present with what is without judging your experience.  You 
may find throughout this exercise that your mind wanders, that your mind is filled 
with thoughts.  And whenever that happens, gently notice that your mind has 
wandered and then bring your mind back to the exercise.   
To begin with find your breath.  Going in and out of your body.  And spend a 
moment.  Just feeling the sensation of breath.  Going in going out.  Feeling your 
abdomen.  Rising and falling feeling the contact points of your body against the floor 
or in the chair and beginning to draw your attention to sensations within your body.  
The purpose of the exercise is just to notice the feelings of your body without trying 
to change the and without judging.  
 So now we will begin going through the body with gentle awareness.  First draw 
your attention down to your right foot.  If you wish.  You can use your breath.  
Breathing in.  Imagining that your breath goes down into your right foot.  Bringing 
with it.  A gentle awareness of sensation.  Noticing.  Whatever it is you feel.  In your 
toes.  In the sole of your foot.  And your heel.  You may feel nothing at all.  And 
that's OK.  You may feel tension.  Warmth coldness.  Whatever it is simply noticing 
it.  With each breath.  Feeling your foot.  And now letting your attention.  Move 
through your ankle and into your right.  Lower leg.  Noticing sensations in your calf 
muscles.  And your shin.  Just watching whatever is going on there.  Using your 
breath to draw your attention.  Trying not to actually visualize your leg.  But to feel it 
from the inside.  Letting attention move now to your right knee.  And then feeling 
your right thigh just noticing.  Sensation in your thigh muscles.  If your mind is 
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wandering.  Let the thoughts.  Float away.  And bring your attention.  Gently back 
with kindness to the feelings in your right thigh.  Now shifting attention to your left 
side allowing your breath to draw attention.  Down to your left foot and noticing all 
the sensations in your left foot in your toes.  In the sole of your foot.  Your heel and 
arch.  The top of your foot.  Allowing your awareness to take in whatever's there.  
Without judging it.  And then allowing awareness to move to your left ankle.  
Feeling any sensations of tension or relaxation.  Letting awareness move to your left 
leg.  Feeling the muscles in your left calf.  Feeling the sensations in your left knee.  
Gently drawing your attention to your left thigh and now.  Noticing any sensation.  
And just letting it be what it is. Bringing your attention gently back to this moment.  
Into sensation feeling both of your legs.  And now gently moving awareness into 
your pelvis.  Feeling your buttocks, your genitals.  Your hips breathing.  Awareness.  
Into the cradle of your pelvis.  Noticing any sensations of energy and attention.  Just 
noticing.  Just holding all sensation.  In your awareness.  Then moving to your lower 
back.  Feeling any tension in the lower muscles surrounding your spine.  Any pain 
any achyeness is using your breath.  To surround your sensation.  With accepting 
awareness.  And then moving your Intention to your belly.  Your abdomen.  
Allowing your breath.  To move deeply into your abdomen.  Becoming aware of the 
multitude of activity within your vital organs.  Just breathing.  Openness and space.  
Into the centre of your abdomen.  Noticing.  Whatever you notice.  And moving your 
attention up to your chest area.  Feeling.  Your heart and your lungs.  Breathing into 
your chest space with great tenderness.  Just feeling.  Whatever sensation is being 
held in that space.  Allowing for whatever sensation.  Whatever emotion.  You 
notice.  As you bring awareness.  To Your Heart Centre.  Now bring your attention to 
your upper back into the muscles of your shoulder blades.  And your shoulders.  The 
place where we all carry tension.  And notice.  What you feel your shoulders.  
Without trying to change it.  Just welcoming sensation.  Within your awareness.  
Breathing gently into your shoulders.  And your upper back.  And now allow 
awareness to move gradually down your right arm.  Feeling your upper arm.  Your 
tricep muscles.  And moving slowly through your elbow your lower right arm.  
Feeling your wrist.  And the back of your hand.  Feeling the palm of your right hand.  
Your fingers.  Allowing awareness to extend right down to your fingertips.  Noticing.  
There may be.  Tingling.  There may be warmth just noticing.  Whatever you feel.  
Now.  Bring your awareness.  To your left shoulder.  Allowing awareness to 
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gradually move down.  Your left arm.  The upper arm and triceps the left elbow.  The 
left forearm.  Wrist.  Feel the back of your left hand.  Feeling the palm of your left 
hand and feeling your left fingers.  Allowing sensation to reach into your left.  
Fingertips.  Just gently noticing.  Every sensation.  Without judging. Gently guiding 
your mind.  Back to sensation.  When you've noticed that it's wandered.  Now move 
your attention up to your neck.  And your throat.  Feeling.  The muscles in the back 
of your neck feeling.  The tender vulnerable area of the front of your throat.  
Noticing if there's any sensation any tension.  And letting your awareness travel.  Up 
the back of your neck.  To your scalp at the back of your head.  Feeling your ears.  
And then moving forward to notice your jaw.  Just notice.  If any tension is held 
there.  Bring attention now to your chin.  And notice the sensations in your lips.  
Noticing the inside of your mouth.  Your tongue.  Your teeth.  And your gums.  The 
inside of your throat.  Now bringing attention to your nose and your cheekbones.  As 
you bring attention to your eyes.  Noticing the many tiny muscles surrounding your 
eyes.  Just noticing all the many sensations. The Feeling of your eyeballs.  Inside 
your eyes sockets.  The feeling of your eyebrows.  And then bring attention to your 
forehead.  And finally bringing attention to the crown of your head noticing any 
sensations of energy.  At the very top of your body.  Now seeing.  If you can bring 
awareness to your entire body at once.  At this point you may not feel any sensation.  
Or you may feel.  Sensation.  Can you experience the field of energy that is your 
body.  Can you rest in your awareness of that whole energy field.  If you'd like.  You 
can imagine.  That as you breathe in the breath and your body through the crown of 
your head and sweeps through your body.  And you exhale in the breath.  Exit 
Through your feet.  And in this way.  You can imagine that you're floating on a 
gentle wave of breath.  Gently moving in and out of your body.  Holding you.  You 
continue to rest in this posture for the next few minutes. “ 
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Appendix 2 – Mental Silence Meditation 
At 4:00pm participants began a guided meditation session which was led by a 
qualified instructor. Participants were instructed to sit comfortably in a chair with 
shoes and restrictive clothing removed.  A guided meditation sequence was played 
out aloud for 4 minutes. Following this participants were instructed on a foot soak 
session where they place their feet in a bucket of salt water for 15 minutes. 
Participants were then told to sit in silent meditation for another 15 minutes while 
instrumental music was played in the background. At the end of this session food 
was served and participants were allowed to leave by 5:00pm.  
A copy of the instruction/information pamphlet is below: 
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A transcript of the guided meditation is below: 
“To be in meditation we begin by sitting up straight and comfortably, palms upwards 
in our laps and we close the eyes and take the attention inside. We begin by placing 
the right hand on the left hip. Pressing it. And here we ask, please give me the true 
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knowledge about myself. Please give me the true knowledge about myself. Then take 
the right hand, up under the rib cage on the right hand side, pressing it gently and 
here we affirm, I am my own master, I am my own master. Now we take the right 
hand up to the heart on the left hand side. And here we are affirm. I am the pure 
spirit. I am. The pure spirit. Now take a right hand up to the shoulder and neck on the 
left hand side reaching across. And here we affirm. I am not guilty. I am not guilty. 
At all. I am not guilty. I am not guilty. At all. Now take the right hand up to the 
forehead. Holding both the temples and here we say I forgive. I forgive everyone for 
everything including myself. I forgive. I forgive. Everyone. And I forgive myself. 
Finally we take our right hand. Raise it up as an expression of a pure desire. We 
place the middle of the palm of the hand. Right on the top of the head. On the 
fontanel or flow zone area. Here we pressed down gently. Rotating the scalp over the 
top of the head. Here we say, please give me the experience of mental silence and 
deep stillness. Please give me the experience of mental silence and deep stillness. 
The expression of our pure desire enables this pure energy to flow up and out the top 
of the head. And we just allow our attention to dissolve into the flow. in silence. In 
meditation. In deep stillness.” 
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Appendix 3 – Participant Survey Form & Diaries 
A participant survey form was handed out at the start of the first session and again at 
the end of the final session. A diary was also required to be kept by all participants. 
These were collected at the start of each session as a marker of attendance and 
compliance to the meditation schedule they were asked to follow. Both the diary and 
survey were given to all participants regardless of the group allocated (mental silence 
or body scan meditation). 
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Pre and Post intervention survey 
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Participants Compliance Diary & Attendance
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